Butyro-1,4-lactone Details
:
IUPAC Name
4-Hydroxybutyricacidlactone
:Chemical Class
:CAS Registry Number
96-48-0
:Description
:Fragrance Type
caramel
Physical and Chemical properties
| PUBCHEM ID | 7302 |
| Molecular Weight (g/mol) | 86.092 |
| Molecular Formula | C4H6O2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 0 |
| IUPAC Name | 4-Hydroxybutyricacidlactone |
| Canonical SMILES | O=C1CCCO1 |
| PUBCHEM IUPAC INCHIKEY | YEJRWHAVMIAJKC-UHFFFAOYSA-N |
| Solubility Level | 4 |
| Vapour Pressure | -0.103 |
Absorption and Metabolism information
| XLOGP3 AA | NA |
| CACTVS TPSA | 0 |
| BBB Level | 2 |
| Absorption Level | 1 |
| EXT PPB#Prediction | 0 |
| AlogP98 | 0.276 |
| EXT CYP2D6#Prediction | 0 |
Toxicological Information
| Mouse Female FDA | Multi-Carcinogen |
| Mouse Male FDA | Multi-Carcinogen |
| Rat Female FDA | Single-Carcinogen |
| Rat Male FDA | Multi-Carcinogen |
| Ames Prediction | Non-Mutagen |
| Developmental / Reproductive Toxicity | Toxic |
| Rat Oral LD50 | 3.42902 |
| Ocular Irritancy | Moderate |
| Hepatotoxic#Prediction | 0 |
| Effected Human Genes | NA |
Ecological Information
| Aerobic Biodegradability Prediction | Degradable |
Hazard(s) Identification
| Physical hazards | not classified |
| Health hazards | Mild |
| Environmental hazards | not classified |
Compound Biological Activity
| Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
|---|---|---|---|---|---|---|
| 1 | 96-48-0 | AAAS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2 | 96-48-0 | ABCC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 3 | 96-48-0 | ABCF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 4 | 96-48-0 | ABCG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 5 | 96-48-0 | ABHD11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 6 | 96-48-0 | ABHD12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 7 | 96-48-0 | ABHD2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA | decreases^expression | 19167446 |
| 8 | 96-48-0 | ACAA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 9 | 96-48-0 | ACAT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 10 | 96-48-0 | ACBD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 11 | 96-48-0 | ACKR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 12 | 96-48-0 | ACLY | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA | affects^cotreatment|increases^expression | 19167446 |
| 13 | 96-48-0 | ACOT4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 14 | 96-48-0 | ACOT7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 15 | 96-48-0 | ACYP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 16 | 96-48-0 | ADAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 17 | 96-48-0 | ADD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 18 | 96-48-0 | AFAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 19 | 96-48-0 | AFF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 20 | 96-48-0 | AGR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 21 | 96-48-0 | AGR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 22 | 96-48-0 | AJUBA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 23 | 96-48-0 | AKAP13 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 24 | 96-48-0 | ALG6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 25 | 96-48-0 | ALG8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 26 | 96-48-0 | AMD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 27 | 96-48-0 | AMMECR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 28 | 96-48-0 | AMOTL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 29 | 96-48-0 | ANLN | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ANLN mRNA | increases^expression | 19167446 |
| 30 | 96-48-0 | ANLN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 31 | 96-48-0 | ANO6 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA | decreases^expression | 19167446 |
| 32 | 96-48-0 | ANO6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 33 | 96-48-0 | ANP32E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA | affects^cotreatment|increases^expression | 19167446 |
| 34 | 96-48-0 | ANXA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 35 | 96-48-0 | ANXA2P2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2P2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 36 | 96-48-0 | ANXA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 37 | 96-48-0 | ANXA9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 38 | 96-48-0 | AP1B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 39 | 96-48-0 | AP1M1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 40 | 96-48-0 | APBB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 41 | 96-48-0 | APOBEC3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of APOBEC3B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 42 | 96-48-0 | AQP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 43 | 96-48-0 | ARFGEF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 44 | 96-48-0 | ARHGDIA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 45 | 96-48-0 | ARHGEF26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 46 | 96-48-0 | ARHGEF37 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 47 | 96-48-0 | ARL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 48 | 96-48-0 | ARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 49 | 96-48-0 | ARX | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 50 | 96-48-0 | ASF1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 51 | 96-48-0 | ASPM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 52 | 96-48-0 | ATAD2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA | increases^expression | 19167446 |
| 53 | 96-48-0 | ATAD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 54 | 96-48-0 | ATF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 55 | 96-48-0 | ATF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 56 | 96-48-0 | ATP1B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 57 | 96-48-0 | ATP23 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 58 | 96-48-0 | ATP2B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 59 | 96-48-0 | ATP2C1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 60 | 96-48-0 | ATP5G1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5G1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 61 | 96-48-0 | ATP6V0E1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 62 | 96-48-0 | ATP9A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 63 | 96-48-0 | ATRX | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ATRX mRNA | decreases^expression | 19167446 |
| 64 | 96-48-0 | ATXN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 65 | 96-48-0 | AURKA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 66 | 96-48-0 | AURKB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 67 | 96-48-0 | AXUD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 68 | 96-48-0 | B3GALNT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 69 | 96-48-0 | B3GNT5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 70 | 96-48-0 | BACE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 71 | 96-48-0 | BACE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 72 | 96-48-0 | BAG3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 73 | 96-48-0 | BARD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 74 | 96-48-0 | BCAR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 75 | 96-48-0 | BCL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 76 | 96-48-0 | BCL2L12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 77 | 96-48-0 | BCL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 78 | 96-48-0 | BCL9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 79 | 96-48-0 | BEX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 80 | 96-48-0 | BHLHE40 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 81 | 96-48-0 | BIRC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 82 | 96-48-0 | BLM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 83 | 96-48-0 | BLNK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 84 | 96-48-0 | BMF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 85 | 96-48-0 | BMP7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 86 | 96-48-0 | BMPR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 87 | 96-48-0 | BRAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 88 | 96-48-0 | BRCA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 89 | 96-48-0 | BRCA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 90 | 96-48-0 | BRI3BP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 91 | 96-48-0 | BRWD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 92 | 96-48-0 | BSDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 93 | 96-48-0 | BSG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 94 | 96-48-0 | BTG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 95 | 96-48-0 | BUB1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 96 | 96-48-0 | C16ORF45 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C16ORF45 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 97 | 96-48-0 | C1ORF112 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 98 | 96-48-0 | C5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 99 | 96-48-0 | C5ORF34 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 100 | 96-48-0 | C9ORF152 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 101 | 96-48-0 | C9ORF40 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 102 | 96-48-0 | CA12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 103 | 96-48-0 | CADM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 104 | 96-48-0 | CALM3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 105 | 96-48-0 | CALU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA | affects^cotreatment|increases^expression | 19167446 |
| 106 | 96-48-0 | CAMK2D | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 107 | 96-48-0 | CAMK2N1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 108 | 96-48-0 | CARHSP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 109 | 96-48-0 | CAST | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 110 | 96-48-0 | CBFB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 111 | 96-48-0 | CBLB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 112 | 96-48-0 | CCDC14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 113 | 96-48-0 | CCDC34 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 114 | 96-48-0 | CCNB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 115 | 96-48-0 | CCNB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 116 | 96-48-0 | CCNE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 117 | 96-48-0 | CCNF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 118 | 96-48-0 | CCPG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 119 | 96-48-0 | CD55 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CD55 mRNA | decreases^expression | 19167446 |
| 120 | 96-48-0 | CD55 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 121 | 96-48-0 | CD59 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 122 | 96-48-0 | CDC25A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 123 | 96-48-0 | CDC25C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 124 | 96-48-0 | CDC27 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 125 | 96-48-0 | CDC45L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 126 | 96-48-0 | CDC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 127 | 96-48-0 | CDC7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 128 | 96-48-0 | CDCA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 129 | 96-48-0 | CDCA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 130 | 96-48-0 | CDCA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 131 | 96-48-0 | CDCA5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 132 | 96-48-0 | CDCA7L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 133 | 96-48-0 | CDCA8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 134 | 96-48-0 | CDH12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 135 | 96-48-0 | CDK1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CDK1 mRNA | increases^expression | 19167446 |
| 136 | 96-48-0 | CDK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 137 | 96-48-0 | CDK2AP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 138 | 96-48-0 | CDK5RAP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 139 | 96-48-0 | CDKN1A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CDKN1A mRNA | decreases^expression | 19167446 |
| 140 | 96-48-0 | CDKN1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 141 | 96-48-0 | CDKN2B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 142 | 96-48-0 | CDKN2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 143 | 96-48-0 | CDKN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 144 | 96-48-0 | CDS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 145 | 96-48-0 | CDT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 146 | 96-48-0 | CEBPD | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 147 | 96-48-0 | CELSR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 148 | 96-48-0 | CENPA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 149 | 96-48-0 | CENPF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 150 | 96-48-0 | CENPH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 151 | 96-48-0 | CENPI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA | affects^cotreatment|increases^expression | 19167446 |
| 152 | 96-48-0 | CENPL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 153 | 96-48-0 | CENPN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 154 | 96-48-0 | CENPO | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA | affects^cotreatment|increases^expression | 19167446 |
| 155 | 96-48-0 | CENPQ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 156 | 96-48-0 | CENPS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 157 | 96-48-0 | CENPU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA | affects^cotreatment|increases^expression | 19167446 |
| 158 | 96-48-0 | CENPW | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA | affects^cotreatment|increases^expression | 19167446 |
| 159 | 96-48-0 | CEP55 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA | increases^expression | 19167446 |
| 160 | 96-48-0 | CEP55 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 161 | 96-48-0 | CEP57 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP57 mRNA | increases^expression | 19167446 |
| 162 | 96-48-0 | CEP78 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 163 | 96-48-0 | CEP85 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 164 | 96-48-0 | CHAC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 165 | 96-48-0 | CHAF1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 166 | 96-48-0 | CHAF1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 167 | 96-48-0 | CHD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 168 | 96-48-0 | CHEK1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CHEK1 mRNA | increases^expression | 19167446 |
| 169 | 96-48-0 | CHEK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 170 | 96-48-0 | CHEK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 171 | 96-48-0 | CHES1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 172 | 96-48-0 | CHPT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 173 | 96-48-0 | CITED2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 174 | 96-48-0 | CKAP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 175 | 96-48-0 | CKLF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 176 | 96-48-0 | CKS1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 177 | 96-48-0 | CKS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 178 | 96-48-0 | CLDN1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CLDN1 mRNA | decreases^expression | 19167446 |
| 179 | 96-48-0 | CLDN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 180 | 96-48-0 | CLDN4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 181 | 96-48-0 | CLIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 182 | 96-48-0 | CLN6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 183 | 96-48-0 | CLU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 184 | 96-48-0 | CMC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 185 | 96-48-0 | COL21A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of COL21A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 186 | 96-48-0 | COL5A1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of COL5A1 mRNA | decreases^expression | 19167446 |
| 187 | 96-48-0 | CRY1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 188 | 96-48-0 | CSE1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 189 | 96-48-0 | CSPG5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 190 | 96-48-0 | CSRNP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 191 | 96-48-0 | CTDSPL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 192 | 96-48-0 | CTNNAL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 193 | 96-48-0 | CTR9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 194 | 96-48-0 | CTTN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 195 | 96-48-0 | CTTNBP2NL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 196 | 96-48-0 | CXXC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 197 | 96-48-0 | CYB5R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 198 | 96-48-0 | CYP19A1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein | decreases^activity | 15876411 |
| 199 | 96-48-0 | CYP2R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 200 | 96-48-0 | CYR61 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYR61 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 201 | 96-48-0 | DANCR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 202 | 96-48-0 | DARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 203 | 96-48-0 | DBF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 204 | 96-48-0 | DBN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 205 | 96-48-0 | DCAF15 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 206 | 96-48-0 | DCAF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 207 | 96-48-0 | DCAF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 208 | 96-48-0 | DCLK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 209 | 96-48-0 | DCLRE1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 210 | 96-48-0 | DCLRE1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 211 | 96-48-0 | DDAH2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 212 | 96-48-0 | DDB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 213 | 96-48-0 | DDEF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDEF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 214 | 96-48-0 | DDIAS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 215 | 96-48-0 | DDX39B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 216 | 96-48-0 | DEPDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 217 | 96-48-0 | DEPDC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 218 | 96-48-0 | DERA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 219 | 96-48-0 | DHFR | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DHFR mRNA | increases^expression | 19167446 |
| 220 | 96-48-0 | DHFR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 221 | 96-48-0 | DHRS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 222 | 96-48-0 | DHTKD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 223 | 96-48-0 | DIAPH3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 224 | 96-48-0 | DIP2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 225 | 96-48-0 | DKC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 226 | 96-48-0 | DLGAP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 227 | 96-48-0 | DLX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 228 | 96-48-0 | DMXL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 229 | 96-48-0 | DNAJA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 230 | 96-48-0 | DNAJB9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 231 | 96-48-0 | DNAJC9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 232 | 96-48-0 | DNASE2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DNASE2 mRNA | increases^expression | 19167446 |
| 233 | 96-48-0 | DNASE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 234 | 96-48-0 | DNM1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 235 | 96-48-0 | DNMT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 236 | 96-48-0 | DONSON | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA | affects^cotreatment|increases^expression | 19167446 |
| 237 | 96-48-0 | DSCC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 238 | 96-48-0 | DSCR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DSCR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 239 | 96-48-0 | DSN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 240 | 96-48-0 | DTNA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 241 | 96-48-0 | DUSP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 242 | 96-48-0 | DUT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 243 | 96-48-0 | DYNC1LI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 244 | 96-48-0 | E2F2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 245 | 96-48-0 | E2F5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 246 | 96-48-0 | E2F7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 247 | 96-48-0 | E2F8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 248 | 96-48-0 | EBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 249 | 96-48-0 | ECT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 250 | 96-48-0 | EDIL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 251 | 96-48-0 | EED | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA | affects^cotreatment|increases^expression | 19167446 |
| 252 | 96-48-0 | EEF1A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 253 | 96-48-0 | EFEMP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 254 | 96-48-0 | EFHD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 255 | 96-48-0 | EFNA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 256 | 96-48-0 | EFNB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 257 | 96-48-0 | EGR1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA | decreases^expression | 19167446 |
| 258 | 96-48-0 | EGR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 259 | 96-48-0 | EGR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 260 | 96-48-0 | ELF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 261 | 96-48-0 | ELK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 262 | 96-48-0 | ELOVL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 263 | 96-48-0 | ELOVL6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 264 | 96-48-0 | ELOVL7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 265 | 96-48-0 | ELP6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 266 | 96-48-0 | EMC9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 267 | 96-48-0 | EME1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 268 | 96-48-0 | ENC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 269 | 96-48-0 | ENDOD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 270 | 96-48-0 | ENOSF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENOSF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 271 | 96-48-0 | EPB41L5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 272 | 96-48-0 | EPHA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 273 | 96-48-0 | EPS15L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 274 | 96-48-0 | ERCC6L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 275 | 96-48-0 | ERI2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 276 | 96-48-0 | ERRFI1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ERRFI1 mRNA | decreases^expression | 19167446 |
| 277 | 96-48-0 | ERRFI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 278 | 96-48-0 | ESPL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 279 | 96-48-0 | EXO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 280 | 96-48-0 | EXOC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 281 | 96-48-0 | EXT1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA | decreases^expression | 19167446 |
| 282 | 96-48-0 | EXT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 283 | 96-48-0 | EZH2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 284 | 96-48-0 | EZR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 285 | 96-48-0 | F2RL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 286 | 96-48-0 | FAM107B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 287 | 96-48-0 | FAM110B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 288 | 96-48-0 | FAM111A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 289 | 96-48-0 | FAM149B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 290 | 96-48-0 | FAM189A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 291 | 96-48-0 | FAM214A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 292 | 96-48-0 | FAM43A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA | decreases^expression | 19167446 |
| 293 | 96-48-0 | FAM43A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 294 | 96-48-0 | FAM49B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM49B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 295 | 96-48-0 | FANCD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 296 | 96-48-0 | FANCG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 297 | 96-48-0 | FANCI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA | affects^cotreatment|increases^expression | 19167446 |
| 298 | 96-48-0 | FANCL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 299 | 96-48-0 | FBXO38 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 300 | 96-48-0 | FBXO5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 301 | 96-48-0 | FCMR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 302 | 96-48-0 | FDFT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 303 | 96-48-0 | FEN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 304 | 96-48-0 | FERMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 305 | 96-48-0 | FIBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 306 | 96-48-0 | FIGNL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 307 | 96-48-0 | FILIP1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 308 | 96-48-0 | FKBP11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 309 | 96-48-0 | FKBP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 310 | 96-48-0 | FLCN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 311 | 96-48-0 | FNBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 312 | 96-48-0 | FNBP1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 313 | 96-48-0 | FOS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 314 | 96-48-0 | FOXM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 315 | 96-48-0 | FOXO3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 316 | 96-48-0 | FOXP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 317 | 96-48-0 | FRMD6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 318 | 96-48-0 | FSCN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 319 | 96-48-0 | FYCO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 320 | 96-48-0 | G2E3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 321 | 96-48-0 | G3BP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 322 | 96-48-0 | GABPB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 323 | 96-48-0 | GADD45A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GADD45A mRNA | decreases^expression | 19167446 |
| 324 | 96-48-0 | GADD45A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 325 | 96-48-0 | GALNS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 326 | 96-48-0 | GALNT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 327 | 96-48-0 | GALNT10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 328 | 96-48-0 | GALNT7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 329 | 96-48-0 | GANAB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 330 | 96-48-0 | GAS2L3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 331 | 96-48-0 | GATA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 332 | 96-48-0 | GBP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 333 | 96-48-0 | GCHFR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 334 | 96-48-0 | GDF15 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 335 | 96-48-0 | GDPD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 336 | 96-48-0 | GEMIN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 337 | 96-48-0 | GFRA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 338 | 96-48-0 | GGCT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 339 | 96-48-0 | GGH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 340 | 96-48-0 | GINS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 341 | 96-48-0 | GINS2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of GINS2 mRNA | increases^expression | 19167446 |
| 342 | 96-48-0 | GINS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 343 | 96-48-0 | GINS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 344 | 96-48-0 | GINS4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 345 | 96-48-0 | GLE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 346 | 96-48-0 | GMNN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 347 | 96-48-0 | GMPS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 348 | 96-48-0 | GNAS | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA | decreases^expression | 19167446 |
| 349 | 96-48-0 | GOLGA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 350 | 96-48-0 | GOT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 351 | 96-48-0 | GPAA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 352 | 96-48-0 | GPAT4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 353 | 96-48-0 | GPRC5A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 354 | 96-48-0 | GPRC5C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 355 | 96-48-0 | GPSM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 356 | 96-48-0 | GPSN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSN2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 357 | 96-48-0 | GRAMD1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 358 | 96-48-0 | GREB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 359 | 96-48-0 | GRHL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 360 | 96-48-0 | GTF2IRD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 361 | 96-48-0 | GTSE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 362 | 96-48-0 | GULP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 363 | 96-48-0 | H2AFV | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFV mRNA | affects^cotreatment|increases^expression | 19167446 |
| 364 | 96-48-0 | H2AFX | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA | affects^cotreatment|increases^expression | 19167446 |
| 365 | 96-48-0 | H2AFZ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFZ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 366 | 96-48-0 | H3F3B | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of H3F3B mRNA | decreases^expression | 19167446 |
| 367 | 96-48-0 | H3F3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3F3B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 368 | 96-48-0 | HADH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 369 | 96-48-0 | HAUS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 370 | 96-48-0 | HAUS4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 371 | 96-48-0 | HEBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 372 | 96-48-0 | HELLS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 373 | 96-48-0 | HELZ2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 374 | 96-48-0 | HERC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 375 | 96-48-0 | HES1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HES1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 376 | 96-48-0 | HIRIP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 377 | 96-48-0 | HIST1H1C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H1C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 378 | 96-48-0 | HIST1H2AC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 379 | 96-48-0 | HIST1H2AE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AE mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 380 | 96-48-0 | HIST1H2BC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 381 | 96-48-0 | HIST1H2BD | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BD mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 382 | 96-48-0 | HIST1H2BG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BG mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 383 | 96-48-0 | HIST1H2BH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BH mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 384 | 96-48-0 | HIST1H3D | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3D mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 385 | 96-48-0 | HIST1H3H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3H mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 386 | 96-48-0 | HIST1H4H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H4H mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 387 | 96-48-0 | HIST2H2BE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST2H2BE mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 388 | 96-48-0 | HIST3H2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST3H2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 389 | 96-48-0 | HJURP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 390 | 96-48-0 | HMGA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 391 | 96-48-0 | HMGB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 392 | 96-48-0 | HMGB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 393 | 96-48-0 | HMGN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGN3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 394 | 96-48-0 | HMMR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMMR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 395 | 96-48-0 | HNRNPH1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HNRNPH1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 396 | 96-48-0 | HOXC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HOXC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 397 | 96-48-0 | HPRT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HPRT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 398 | 96-48-0 | HS6ST2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HS6ST2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 399 | 96-48-0 | HSD17B1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of HSD17B1 protein | decreases^activity | 15876411 |
| 400 | 96-48-0 | HSD17B6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 401 | 96-48-0 | HSPA4L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSPA4L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 402 | 96-48-0 | HYLS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HYLS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 403 | 96-48-0 | ICA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 404 | 96-48-0 | ICE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 405 | 96-48-0 | ICMT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 406 | 96-48-0 | ID3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ID3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 407 | 96-48-0 | IDS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IDS mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 408 | 96-48-0 | IER2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 409 | 96-48-0 | IER5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 410 | 96-48-0 | IFI44L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFI44L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 411 | 96-48-0 | IFIT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFIT2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 412 | 96-48-0 | IFRD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 413 | 96-48-0 | IFT122 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT122 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 414 | 96-48-0 | IFT20 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT20 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 415 | 96-48-0 | IFT43 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT43 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 416 | 96-48-0 | IGFBP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 417 | 96-48-0 | IGFBP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 418 | 96-48-0 | IGFBP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 419 | 96-48-0 | IGFLR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFLR1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 420 | 96-48-0 | IL1R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IL1R1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 421 | 96-48-0 | IL20 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IL20 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 422 | 96-48-0 | ILF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 423 | 96-48-0 | ILVBL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILVBL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 424 | 96-48-0 | INCENP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 425 | 96-48-0 | INHBB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of INHBB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 426 | 96-48-0 | INO80E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INO80E mRNA | affects^cotreatment|increases^expression | 19167446 |
| 427 | 96-48-0 | INSIG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 428 | 96-48-0 | IP6K2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 429 | 96-48-0 | IQCK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IQCK mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 430 | 96-48-0 | IQGAP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 431 | 96-48-0 | IRF6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 432 | 96-48-0 | IRF9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 433 | 96-48-0 | IRS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 434 | 96-48-0 | ISYNA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ISYNA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 435 | 96-48-0 | ITGA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITGA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 436 | 96-48-0 | ITGAE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGAE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 437 | 96-48-0 | ITGB3BP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGB3BP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 438 | 96-48-0 | ITPR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITPR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 439 | 96-48-0 | JAG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JAG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 440 | 96-48-0 | JMY | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JMY mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 441 | 96-48-0 | JUN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 442 | 96-48-0 | JUNB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUNB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 443 | 96-48-0 | KDM4B | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM4B mRNA | decreases^expression | 19167446 |
| 444 | 96-48-0 | KDM5A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA | decreases^expression | 19167446 |
| 445 | 96-48-0 | KDM5B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 446 | 96-48-0 | KDR | Mus musculus | 2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] | decreases^reaction|increases^expression | 17289903 |
| 447 | 96-48-0 | KIAA0100 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 448 | 96-48-0 | KIAA0513 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 449 | 96-48-0 | KIAA1147 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1147 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 450 | 96-48-0 | KIAA1211 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1211 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 451 | 96-48-0 | KIDINS220 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIDINS220 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 452 | 96-48-0 | KIF11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 453 | 96-48-0 | KIF14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 454 | 96-48-0 | KIF18A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 455 | 96-48-0 | KIF20A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF20A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 456 | 96-48-0 | KIF2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 457 | 96-48-0 | KIF5C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIF5C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 458 | 96-48-0 | KIFC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIFC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 459 | 96-48-0 | KLF12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF12 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 460 | 96-48-0 | KLF6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 461 | 96-48-0 | KLF9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 462 | 96-48-0 | KLHDC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KLHDC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 463 | 96-48-0 | KLHL24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL24 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 464 | 96-48-0 | KLHL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 465 | 96-48-0 | KMT2E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KMT2E mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 466 | 96-48-0 | KNSTRN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 467 | 96-48-0 | KNTC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNTC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 468 | 96-48-0 | KPNA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KPNA4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 469 | 96-48-0 | KRT80 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KRT80 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 470 | 96-48-0 | L1CAM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 471 | 96-48-0 | L2HGDH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 472 | 96-48-0 | LAGE3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LAGE3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 473 | 96-48-0 | LARP6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LARP6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 474 | 96-48-0 | LCMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 475 | 96-48-0 | LDLR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LDLR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 476 | 96-48-0 | LEPR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 477 | 96-48-0 | LGALS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 478 | 96-48-0 | LIG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LIG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 479 | 96-48-0 | LINC00052 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LINC00052 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 480 | 96-48-0 | LMNB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 481 | 96-48-0 | LMNB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 482 | 96-48-0 | LRIG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 483 | 96-48-0 | LRR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRR1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 484 | 96-48-0 | LSM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LSM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 485 | 96-48-0 | MAD2L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAD2L1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 486 | 96-48-0 | MAFF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 487 | 96-48-0 | MAGI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAGI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 488 | 96-48-0 | MALAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MALAT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 489 | 96-48-0 | MAP1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 490 | 96-48-0 | MAP4K4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 491 | 96-48-0 | MAST4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 492 | 96-48-0 | MASTL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MASTL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 493 | 96-48-0 | MATN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 494 | 96-48-0 | MAZ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAZ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 495 | 96-48-0 | MB21D2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MB21D2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 496 | 96-48-0 | MCAM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCAM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 497 | 96-48-0 | MCM10 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of MCM10 mRNA | increases^expression | 19167446 |
| 498 | 96-48-0 | MCM10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 499 | 96-48-0 | MCM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 500 | 96-48-0 | MCM3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 501 | 96-48-0 | MCM4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 502 | 96-48-0 | MCM5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 503 | 96-48-0 | MCM6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 504 | 96-48-0 | MCM7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 505 | 96-48-0 | MCM8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 506 | 96-48-0 | MCUB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 507 | 96-48-0 | MDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MDC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 508 | 96-48-0 | MEA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 509 | 96-48-0 | MEAF6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEAF6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 510 | 96-48-0 | MEF2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 511 | 96-48-0 | MELK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MELK mRNA | affects^cotreatment|increases^expression | 19167446 |
| 512 | 96-48-0 | MEPCE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEPCE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 513 | 96-48-0 | METAP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of METAP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 514 | 96-48-0 | METTL7A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of METTL7A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 515 | 96-48-0 | MGAT4B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGAT4B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 516 | 96-48-0 | MGLL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 517 | 96-48-0 | MGP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MGP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 518 | 96-48-0 | MIR21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MIR21 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 519 | 96-48-0 | MIS18BP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 520 | 96-48-0 | MKI67 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 521 | 96-48-0 | MKNK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 522 | 96-48-0 | MLH1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 523 | 96-48-0 | MOAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MOAP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 524 | 96-48-0 | MPHOSPH9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 525 | 96-48-0 | MRE11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 526 | 96-48-0 | MRM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 527 | 96-48-0 | MRPL37 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 528 | 96-48-0 | MRPS26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS26 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 529 | 96-48-0 | MRPS27 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS27 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 530 | 96-48-0 | MSH6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MSH6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 531 | 96-48-0 | MTCP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTCP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 532 | 96-48-0 | MTFP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTFP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 533 | 96-48-0 | MTHFD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTHFD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 534 | 96-48-0 | MTMR4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTMR4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 535 | 96-48-0 | MTUS1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of MTUS1 mRNA | decreases^expression | 19167446 |
| 536 | 96-48-0 | MTUS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MTUS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 537 | 96-48-0 | MVP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MVP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 538 | 96-48-0 | MXD4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 539 | 96-48-0 | MYB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 540 | 96-48-0 | MYBL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYBL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 541 | 96-48-0 | MYCBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYCBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 542 | 96-48-0 | MYLIP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 543 | 96-48-0 | MYO1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO1B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 544 | 96-48-0 | MYO5A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 545 | 96-48-0 | MYO5B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 546 | 96-48-0 | MYO6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 547 | 96-48-0 | MZT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MZT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 548 | 96-48-0 | N4BP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 549 | 96-48-0 | NAA50 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NAA50 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 550 | 96-48-0 | NANOS1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of NANOS1 mRNA | decreases^expression | 19167446 |
| 551 | 96-48-0 | NANOS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NANOS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 552 | 96-48-0 | NASP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 553 | 96-48-0 | NBEA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 554 | 96-48-0 | NBEAL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEAL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 555 | 96-48-0 | NBPF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 556 | 96-48-0 | NCAPG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 557 | 96-48-0 | NCAPG2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 558 | 96-48-0 | NCOA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 559 | 96-48-0 | NCOA7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 560 | 96-48-0 | NDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 561 | 96-48-0 | NDE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 562 | 96-48-0 | NDFIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NDFIP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 563 | 96-48-0 | NEAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEAT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 564 | 96-48-0 | NEBL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEBL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 565 | 96-48-0 | NEDD4L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD4L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 566 | 96-48-0 | NEDD9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 567 | 96-48-0 | NEIL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 568 | 96-48-0 | NEURL1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 569 | 96-48-0 | NFATC2IP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 570 | 96-48-0 | NFIL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 571 | 96-48-0 | NINL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NINL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 572 | 96-48-0 | NMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 573 | 96-48-0 | NMU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NMU mRNA | affects^cotreatment|increases^expression | 19167446 |
| 574 | 96-48-0 | NOM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NOM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 575 | 96-48-0 | NPAS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPAS3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 576 | 96-48-0 | NPEPPS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPEPPS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 577 | 96-48-0 | NPHP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPHP3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 578 | 96-48-0 | NPNT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPNT mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 579 | 96-48-0 | NPY1R | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPY1R mRNA | affects^cotreatment|increases^expression | 19167446 |
| 580 | 96-48-0 | NQO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NQO1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 581 | 96-48-0 | NQO2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 582 | 96-48-0 | NR1I2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased activity of NR1I2 protein | increases^activity | 15885729 |
| 583 | 96-48-0 | NR2F6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NR2F6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 584 | 96-48-0 | NR4A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 585 | 96-48-0 | NRCAM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NRCAM mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 586 | 96-48-0 | NRM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 587 | 96-48-0 | NSD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NSD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 588 | 96-48-0 | NT5E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 589 | 96-48-0 | NTN4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NTN4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 590 | 96-48-0 | NUAK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NUAK1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 591 | 96-48-0 | NUDT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUDT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 592 | 96-48-0 | NUP107 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 593 | 96-48-0 | NUP155 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 594 | 96-48-0 | NUP210 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 595 | 96-48-0 | NUP62CL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 596 | 96-48-0 | NUSAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 597 | 96-48-0 | OAZ2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OAZ2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 598 | 96-48-0 | ODF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ODF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 599 | 96-48-0 | OIP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OIP5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 600 | 96-48-0 | OLFM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 601 | 96-48-0 | OPTN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OPTN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 602 | 96-48-0 | ORC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 603 | 96-48-0 | ORC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 604 | 96-48-0 | OSBPL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSBPL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 605 | 96-48-0 | OSER1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 606 | 96-48-0 | OTUD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OTUD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 607 | 96-48-0 | OXCT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 608 | 96-48-0 | OXTR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OXTR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 609 | 96-48-0 | P4HB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of P4HB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 610 | 96-48-0 | PAICS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PAICS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 611 | 96-48-0 | PAPSS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAPSS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 612 | 96-48-0 | PARP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 613 | 96-48-0 | PARP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 614 | 96-48-0 | PARPBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARPBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 615 | 96-48-0 | PARVA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PARVA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 616 | 96-48-0 | PAWR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 617 | 96-48-0 | PBK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PBK mRNA | affects^cotreatment|increases^expression | 19167446 |
| 618 | 96-48-0 | PCK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 619 | 96-48-0 | PCLAF | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA | increases^expression | 19167446 |
| 620 | 96-48-0 | PCLAF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 621 | 96-48-0 | PCMTD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 622 | 96-48-0 | PCNA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 623 | 96-48-0 | PCNT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 624 | 96-48-0 | PCSK6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCSK6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 625 | 96-48-0 | PCTK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 626 | 96-48-0 | PDCD4 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PDCD4 mRNA | increases^expression | 19167446 |
| 627 | 96-48-0 | PDCD6IP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDCD6IP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 628 | 96-48-0 | PDIA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 629 | 96-48-0 | PDIA6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 630 | 96-48-0 | PDLIM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDLIM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 631 | 96-48-0 | PDZK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDZK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 632 | 96-48-0 | PFKL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PFKL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 633 | 96-48-0 | PGGT1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGGT1B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 634 | 96-48-0 | PGM2L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM2L1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 635 | 96-48-0 | PGM3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 636 | 96-48-0 | PGRMC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PGRMC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 637 | 96-48-0 | PGRMC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGRMC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 638 | 96-48-0 | PHACTR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 639 | 96-48-0 | PHF19 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PHF19 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 640 | 96-48-0 | PHF20L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHF20L1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 641 | 96-48-0 | PHLDA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 642 | 96-48-0 | PHLDB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 643 | 96-48-0 | PIK3C3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PIK3C3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 644 | 96-48-0 | PIMREG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 645 | 96-48-0 | PKIB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKIB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 646 | 96-48-0 | PKM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 647 | 96-48-0 | PKMYT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 648 | 96-48-0 | PLCXD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 649 | 96-48-0 | PLEKHA5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHA5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 650 | 96-48-0 | PLEKHB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 651 | 96-48-0 | PLK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 652 | 96-48-0 | PLK4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 653 | 96-48-0 | PLOD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLOD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 654 | 96-48-0 | PMEPA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMEPA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 655 | 96-48-0 | PMPCB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMPCB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 656 | 96-48-0 | PNP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PNP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 657 | 96-48-0 | POLA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 658 | 96-48-0 | POLA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 659 | 96-48-0 | POLD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 660 | 96-48-0 | POLD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 661 | 96-48-0 | POLD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 662 | 96-48-0 | POLE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 663 | 96-48-0 | POLE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 664 | 96-48-0 | POLE3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 665 | 96-48-0 | PPAT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPAT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 666 | 96-48-0 | PPIF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPIF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 667 | 96-48-0 | PPL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 668 | 96-48-0 | PPP1R10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPP1R10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 669 | 96-48-0 | PPP2R2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 670 | 96-48-0 | PPP2R3A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R3A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 671 | 96-48-0 | PPP3CC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP3CC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 672 | 96-48-0 | PRDX4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRDX4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 673 | 96-48-0 | PREX1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PREX1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 674 | 96-48-0 | PRIM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 675 | 96-48-0 | PRIM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 676 | 96-48-0 | PRKDC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA | affects^cotreatment|increases^expression | 19167446 |
| 677 | 96-48-0 | PRPF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRPF4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 678 | 96-48-0 | PRR14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRR14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 679 | 96-48-0 | PRRC2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 680 | 96-48-0 | PRRC2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRC2C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 681 | 96-48-0 | PRRT3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRT3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 682 | 96-48-0 | PRSS23 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of PRSS23 mRNA | decreases^expression | 19167446 |
| 683 | 96-48-0 | PRSS23 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRSS23 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 684 | 96-48-0 | PSIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSIP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 685 | 96-48-0 | PSMC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSMC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 686 | 96-48-0 | PSRC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSRC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 687 | 96-48-0 | PTBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 688 | 96-48-0 | PTGES | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTGES mRNA | affects^cotreatment|increases^expression | 19167446 |
| 689 | 96-48-0 | PTP4A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTP4A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 690 | 96-48-0 | PTPN12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN12 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 691 | 96-48-0 | PTPN21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN21 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 692 | 96-48-0 | PTTG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTTG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 693 | 96-48-0 | PUS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PUS3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 694 | 96-48-0 | PYROXD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 695 | 96-48-0 | QSER1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of QSER1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 696 | 96-48-0 | RAB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 697 | 96-48-0 | RAB31 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB31 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 698 | 96-48-0 | RAB32 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB32 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 699 | 96-48-0 | RAB40B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 700 | 96-48-0 | RAB8A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB8A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 701 | 96-48-0 | RACGAP1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA | increases^expression | 19167446 |
| 702 | 96-48-0 | RACGAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 703 | 96-48-0 | RAD21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD21 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 704 | 96-48-0 | RAD51 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 705 | 96-48-0 | RAD51AP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 706 | 96-48-0 | RAD51C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 707 | 96-48-0 | RAD54B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 708 | 96-48-0 | RAD54L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 709 | 96-48-0 | RANBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 710 | 96-48-0 | RANGAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANGAP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 711 | 96-48-0 | RAPGEF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 712 | 96-48-0 | RAPGEFL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAPGEFL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 713 | 96-48-0 | RASD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 714 | 96-48-0 | RASEF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 715 | 96-48-0 | RASL11B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 716 | 96-48-0 | RASSF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASSF3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 717 | 96-48-0 | RAVER1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 718 | 96-48-0 | RB1CC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 719 | 96-48-0 | RBBP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 720 | 96-48-0 | RBBP8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 721 | 96-48-0 | RBBP9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 722 | 96-48-0 | RBFOX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 723 | 96-48-0 | RBM10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 724 | 96-48-0 | RBM15 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM15 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 725 | 96-48-0 | RBMS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 726 | 96-48-0 | RCCD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RCCD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 727 | 96-48-0 | RCOR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RCOR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 728 | 96-48-0 | RDM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RDM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 729 | 96-48-0 | RECQL4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RECQL4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 730 | 96-48-0 | REEP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of REEP3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 731 | 96-48-0 | REEP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 732 | 96-48-0 | RERG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RERG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 733 | 96-48-0 | RET | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RET mRNA | affects^cotreatment|increases^expression | 19167446 |
| 734 | 96-48-0 | RFC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 735 | 96-48-0 | RFC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 736 | 96-48-0 | RFC4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 737 | 96-48-0 | RFC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 738 | 96-48-0 | RFTN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 739 | 96-48-0 | RGS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RGS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 740 | 96-48-0 | RHBDF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 741 | 96-48-0 | RHNO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RHNO1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 742 | 96-48-0 | RHOQ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOQ mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 743 | 96-48-0 | RHOT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 744 | 96-48-0 | RMDN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RMDN2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 745 | 96-48-0 | RMI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 746 | 96-48-0 | RMI2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA | increases^expression | 19167446 |
| 747 | 96-48-0 | RMI2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 748 | 96-48-0 | RNASEH2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNASEH2A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 749 | 96-48-0 | RNF187 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF187 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 750 | 96-48-0 | RNF19A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RNF19A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 751 | 96-48-0 | RNF26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 752 | 96-48-0 | ROCK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 753 | 96-48-0 | RPA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 754 | 96-48-0 | RPA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 755 | 96-48-0 | RPL39L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPL39L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 756 | 96-48-0 | RRAGC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RRAGC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 757 | 96-48-0 | RRM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 758 | 96-48-0 | RRM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 759 | 96-48-0 | RSRC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 760 | 96-48-0 | RSU1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 761 | 96-48-0 | RUNDC3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RUNDC3B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 762 | 96-48-0 | S100A10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 763 | 96-48-0 | S1PR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 764 | 96-48-0 | SAE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SAE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 765 | 96-48-0 | SALL4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SALL4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 766 | 96-48-0 | SASH1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SASH1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 767 | 96-48-0 | SAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SAT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 768 | 96-48-0 | SCARB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SCARB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 769 | 96-48-0 | SCARB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCARB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 770 | 96-48-0 | SCCPDH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCCPDH mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 771 | 96-48-0 | SELENOP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SELENOP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 772 | 96-48-0 | SEPHS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SEPHS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 773 | 96-48-0 | SERINC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 774 | 96-48-0 | SF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 775 | 96-48-0 | SF3B3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF3B3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 776 | 96-48-0 | SFN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 777 | 96-48-0 | SFXN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 778 | 96-48-0 | SGCG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SGCG mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 779 | 96-48-0 | SGK3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 780 | 96-48-0 | SGO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 781 | 96-48-0 | SGO2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 782 | 96-48-0 | SH3BGRL | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SH3BGRL mRNA | decreases^expression | 19167446 |
| 783 | 96-48-0 | SH3BGRL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BGRL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 784 | 96-48-0 | SH3BP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BP4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 785 | 96-48-0 | SH3KBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3KBP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 786 | 96-48-0 | SHCBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 787 | 96-48-0 | SHISA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SHISA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 788 | 96-48-0 | SHMT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 789 | 96-48-0 | SHMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 790 | 96-48-0 | SKA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 791 | 96-48-0 | SKA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 792 | 96-48-0 | SKA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 793 | 96-48-0 | SKP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 794 | 96-48-0 | SLBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 795 | 96-48-0 | SLC12A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 796 | 96-48-0 | SLC12A4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 797 | 96-48-0 | SLC12A8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 798 | 96-48-0 | SLC1A4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC1A4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 799 | 96-48-0 | SLC25A11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 800 | 96-48-0 | SLC25A39 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A39 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 801 | 96-48-0 | SLC26A11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 802 | 96-48-0 | SLC27A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 803 | 96-48-0 | SLC27A3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 804 | 96-48-0 | SLC29A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 805 | 96-48-0 | SLC2A4RG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 806 | 96-48-0 | SLC35D2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC35D2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 807 | 96-48-0 | SLC37A4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC37A4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 808 | 96-48-0 | SLC39A8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 809 | 96-48-0 | SLC6A14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC6A14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 810 | 96-48-0 | SLC7A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 811 | 96-48-0 | SLC7A11 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA | decreases^expression | 19167446 |
| 812 | 96-48-0 | SLC7A11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 813 | 96-48-0 | SLC7A5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 814 | 96-48-0 | SLC9A3R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC9A3R1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 815 | 96-48-0 | SLF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 816 | 96-48-0 | SMAD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 817 | 96-48-0 | SMAD3 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SMAD3 mRNA | decreases^expression | 19167446 |
| 818 | 96-48-0 | SMAD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 819 | 96-48-0 | SMC1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC1A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 820 | 96-48-0 | SMC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 821 | 96-48-0 | SMC4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 822 | 96-48-0 | SMYD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMYD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 823 | 96-48-0 | SNHG7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNHG7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 824 | 96-48-0 | SNN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 825 | 96-48-0 | SNORA24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORA24 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 826 | 96-48-0 | SNORD52 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORD52 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 827 | 96-48-0 | SNRNP25 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRNP25 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 828 | 96-48-0 | SNRPA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 829 | 96-48-0 | SNRPB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 830 | 96-48-0 | SNX10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 831 | 96-48-0 | SNX24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 832 | 96-48-0 | SNX29 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 833 | 96-48-0 | SNX6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 834 | 96-48-0 | SNX9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 835 | 96-48-0 | SOCS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 836 | 96-48-0 | SOX3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SOX3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 837 | 96-48-0 | SOX4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 838 | 96-48-0 | SOX9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 839 | 96-48-0 | SPAG5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 840 | 96-48-0 | SPATA7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 841 | 96-48-0 | SPC24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 842 | 96-48-0 | SPC25 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 843 | 96-48-0 | SPDL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPDL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 844 | 96-48-0 | SPIN4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPIN4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 845 | 96-48-0 | SPRED2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 846 | 96-48-0 | SQOR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQOR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 847 | 96-48-0 | SQSTM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 848 | 96-48-0 | SRD5A3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRD5A3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 849 | 96-48-0 | SRI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SRI mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 850 | 96-48-0 | SRM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 851 | 96-48-0 | SRPRB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 852 | 96-48-0 | SRSF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 853 | 96-48-0 | SSBP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 854 | 96-48-0 | SSRP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SSRP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 855 | 96-48-0 | ST8SIA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ST8SIA4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 856 | 96-48-0 | STIL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 857 | 96-48-0 | STK38L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STK38L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 858 | 96-48-0 | STMN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STMN1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 859 | 96-48-0 | STON2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 860 | 96-48-0 | STRN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STRN3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 861 | 96-48-0 | STX3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 862 | 96-48-0 | STX7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 863 | 96-48-0 | SULF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 864 | 96-48-0 | SUPT16H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUPT16H mRNA | affects^cotreatment|increases^expression | 19167446 |
| 865 | 96-48-0 | SUV39H2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 866 | 96-48-0 | SWAP70 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 867 | 96-48-0 | SYCE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 868 | 96-48-0 | SYDE2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SYDE2 mRNA | decreases^expression | 19167446 |
| 869 | 96-48-0 | SYDE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYDE2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 870 | 96-48-0 | SYNGR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 871 | 96-48-0 | SYTL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 872 | 96-48-0 | SYTL4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 873 | 96-48-0 | SYTL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 874 | 96-48-0 | TACC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 875 | 96-48-0 | TACSTD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 876 | 96-48-0 | TAF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 877 | 96-48-0 | TANC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 878 | 96-48-0 | TAOK3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 879 | 96-48-0 | TARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 880 | 96-48-0 | TBCD | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TBCD mRNA | affects^cotreatment|increases^expression | 19167446 |
| 881 | 96-48-0 | TBL1X | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TBL1X mRNA | decreases^expression | 19167446 |
| 882 | 96-48-0 | TCF19 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA | increases^expression | 19167446 |
| 883 | 96-48-0 | TCF19 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 884 | 96-48-0 | TCF7L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TCF7L1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 885 | 96-48-0 | TDP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TDP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 886 | 96-48-0 | TEX30 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TEX30 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 887 | 96-48-0 | TFAP2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 888 | 96-48-0 | TFDP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFDP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 889 | 96-48-0 | TFF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 890 | 96-48-0 | TFF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 891 | 96-48-0 | TFPI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 892 | 96-48-0 | TGFB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 893 | 96-48-0 | TGFBR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFBR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 894 | 96-48-0 | TGIF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGIF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 895 | 96-48-0 | TGIF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TGIF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 896 | 96-48-0 | THBS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THBS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 897 | 96-48-0 | THEM6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THEM6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 898 | 96-48-0 | THSD4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 899 | 96-48-0 | TICRR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TICRR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 900 | 96-48-0 | TIGAR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIGAR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 901 | 96-48-0 | TIMELESS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 902 | 96-48-0 | TIMP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIMP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 903 | 96-48-0 | TIPIN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 904 | 96-48-0 | TK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 905 | 96-48-0 | TKFC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA | affects^cotreatment|increases^expression | 19167446 |
| 906 | 96-48-0 | TLE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TLE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 907 | 96-48-0 | TM4SF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 908 | 96-48-0 | TMCC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMCC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 909 | 96-48-0 | TMED8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMED8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 910 | 96-48-0 | TMEM106C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM106C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 911 | 96-48-0 | TMEM164 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM164 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 912 | 96-48-0 | TMEM237 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM237 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 913 | 96-48-0 | TMEM38B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 914 | 96-48-0 | TMEM45B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 915 | 96-48-0 | TMEM64 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 916 | 96-48-0 | TMEM65 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 917 | 96-48-0 | TMEM97 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 918 | 96-48-0 | TMPO | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA | affects^cotreatment|increases^expression | 19167446 |
| 919 | 96-48-0 | TMPRSS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPRSS3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 920 | 96-48-0 | TMSB15A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMSB15A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 921 | 96-48-0 | TMTC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMTC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 922 | 96-48-0 | TNFAIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 923 | 96-48-0 | TNFRSF12A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF12A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 924 | 96-48-0 | TNFRSF21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF21 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 925 | 96-48-0 | TOP2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOP2A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 926 | 96-48-0 | TOPBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOPBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 927 | 96-48-0 | TP53INP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TP53INP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 928 | 96-48-0 | TPD52 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 929 | 96-48-0 | TPD52L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPD52L1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 930 | 96-48-0 | TPI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPI1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 931 | 96-48-0 | TPM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 932 | 96-48-0 | TPX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPX2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 933 | 96-48-0 | TRERF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRERF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 934 | 96-48-0 | TRIB1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA | decreases^expression | 19167446 |
| 935 | 96-48-0 | TRIB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 936 | 96-48-0 | TRIM59 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIM59 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 937 | 96-48-0 | TRIP13 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 938 | 96-48-0 | TSC22D3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSC22D3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 939 | 96-48-0 | TSN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TSN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 940 | 96-48-0 | TSPAN31 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPAN31 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 941 | 96-48-0 | TSPYL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPYL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 942 | 96-48-0 | TTC39B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 943 | 96-48-0 | TTK | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA | increases^expression | 19167446 |
| 944 | 96-48-0 | TTK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA | affects^cotreatment|increases^expression | 19167446 |
| 945 | 96-48-0 | TUBA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 946 | 96-48-0 | TUBB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 947 | 96-48-0 | TUBB2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUBB2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 948 | 96-48-0 | TUBB4B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 949 | 96-48-0 | TUBD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 950 | 96-48-0 | TUBG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 951 | 96-48-0 | TUBGCP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBGCP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 952 | 96-48-0 | TUFT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUFT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 953 | 96-48-0 | TULP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TULP4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 954 | 96-48-0 | TWIST1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 955 | 96-48-0 | TYMS | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TYMS mRNA | increases^expression | 19167446 |
| 956 | 96-48-0 | TYMS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TYMS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 957 | 96-48-0 | UBE2B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 958 | 96-48-0 | UBE2H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2H mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 959 | 96-48-0 | UBE2J1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 960 | 96-48-0 | UBE2QL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2QL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 961 | 96-48-0 | UBE2T | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBE2T mRNA | affects^cotreatment|increases^expression | 19167446 |
| 962 | 96-48-0 | UBE2W | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 963 | 96-48-0 | UBR7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBR7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 964 | 96-48-0 | UCHL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 965 | 96-48-0 | UCK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 966 | 96-48-0 | UHRF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UHRF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 967 | 96-48-0 | UNG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UNG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 968 | 96-48-0 | UPF3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UPF3B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 969 | 96-48-0 | USP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 970 | 96-48-0 | USP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of USP3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 971 | 96-48-0 | UST | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 972 | 96-48-0 | VARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 973 | 96-48-0 | VEGFA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of VEGFA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 974 | 96-48-0 | VKORC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 975 | 96-48-0 | VRK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 976 | 96-48-0 | WDHD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDHD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 977 | 96-48-0 | WDR34 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR34 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 978 | 96-48-0 | WDR54 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR54 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 979 | 96-48-0 | WDR76 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR76 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 980 | 96-48-0 | WIPI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of WIPI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 981 | 96-48-0 | WISP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WISP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 982 | 96-48-0 | WIZ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WIZ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 983 | 96-48-0 | YPEL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 984 | 96-48-0 | YPEL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 985 | 96-48-0 | YWHAE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of YWHAE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 986 | 96-48-0 | ZBTB26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB26 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 987 | 96-48-0 | ZBTB4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 988 | 96-48-0 | ZC2HC1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC2HC1A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 989 | 96-48-0 | ZC3H12A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC3H12A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 990 | 96-48-0 | ZDHHC7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZDHHC7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 991 | 96-48-0 | ZFAND2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFAND2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 992 | 96-48-0 | ZFYVE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFYVE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 993 | 96-48-0 | ZKSCAN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZKSCAN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 994 | 96-48-0 | ZMYM5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZMYM5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 995 | 96-48-0 | ZNF160 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ZNF160 mRNA | decreases^expression | 19167446 |
| 996 | 96-48-0 | ZNF277 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF277 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 997 | 96-48-0 | ZNF292 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF292 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 998 | 96-48-0 | ZNF354A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF354A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 999 | 96-48-0 | ZNF367 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1000 | 96-48-0 | ZNF467 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF467 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1001 | 96-48-0 | ZNF641 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF641 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1002 | 96-48-0 | ZNF703 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1003 | 96-48-0 | ZNF718 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF718 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1004 | 96-48-0 | ZWILCH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWILCH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1005 | 96-48-0 | ZWINT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWINT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1006 | 96-48-0 | ZXDB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZXDB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1007 | 96-48-0 | FGF2 | 3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one affects the susceptibility to FGF2 protein | affects^response to substance | 19199859 | |
| 1008 | 96-48-0 | ATG5 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of ATG5 protein | decreases^expression | 28408137 |
| 1009 | 96-48-0 | ATG7 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of ATG7 protein | decreases^expression | 28408137 |
| 1010 | 96-48-0 | CTNNB1 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of CTNNB1 mRNA | decreases^expression | 26235807 |
| 1011 | 96-48-0 | EZH2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of EZH2 protein | decreases^expression | 26235807 |
| 1012 | 96-48-0 | JAK2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of JAK2 protein | decreases^expression | 26235807 |
| 1013 | 96-48-0 | JAK2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of JAK2 protein modified form | decreases^expression | 26235807 |
| 1014 | 96-48-0 | LGR5 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of LGR5 mRNA | decreases^expression | 26235807 |
| 1015 | 96-48-0 | LGR5 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of LGR5 protein | decreases^expression | 26235807 |
| 1016 | 96-48-0 | NANOG | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of NANOG protein | decreases^expression | 26235807 |
| 1017 | 96-48-0 | SMO | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of SMO mRNA | decreases^expression | 26235807 |
| 1018 | 96-48-0 | SOX2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of SOX2 mRNA | decreases^expression | 26235807 |
| 1019 | 96-48-0 | SUZ12 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of SUZ12 protein | decreases^expression | 26235807 |
| 1020 | 96-48-0 | TYK2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of TYK2 protein | decreases^expression | 26235807 |
| 1021 | 96-48-0 | HPGDS | Mus musculus | [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA | affects^cotreatment|increases^expression | 21669866 |
| 1022 | 96-48-0 | HPGDS | Mus musculus | [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein | affects^cotreatment|increases^expression | 21669866 |
| 1023 | 96-48-0 | BIRC2 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC2 protein | decreases^expression | 21442130 |
| 1024 | 96-48-0 | BIRC3 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC3 protein | decreases^expression | 21442130 |
| 1025 | 96-48-0 | CASP3 | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in decreased expression of CASP3 protein | affects^cotreatment|decreases^expression|increases^cleavage | 21442130 |
| 1026 | 96-48-0 | CASP3 | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in increased activity of CASP3 protein | affects^cotreatment|increases^activity|increases^cleavage | 21442130 |
| 1027 | 96-48-0 | CASP3 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased cleavage of and results in increased activity of CASP3 protein | increases^activity|increases^cleavage | 21442130 |
| 1028 | 96-48-0 | CASP9 | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein | affects^cotreatment|increases^activity | 21442130 |
| 1029 | 96-48-0 | CASP9 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein | increases^activity | 21442130 |
| 1030 | 96-48-0 | CEBPA | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of CEBPA mRNA | decreases^expression | 15707987 |
| 1031 | 96-48-0 | DDIT3 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased expression of DDIT3 mRNA | increases^expression | 17283163 |
| 1032 | 96-48-0 | FASN | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein | affects^binding|decreases^activity | 17847090 |
| 1033 | 96-48-0 | FASN | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein | affects^cotreatment|decreases^expression | 21442130 |
| 1034 | 96-48-0 | FASN | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein | decreases^activity | 21442130 |
| 1035 | 96-48-0 | FASN | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin | decreases^activity|increases^response to substance | 21442130 |
| 1036 | 96-48-0 | FASN | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA | decreases^expression | 15707987 |
| 1037 | 96-48-0 | FOS | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid affects the expression of FOS protein | affects^expression | 12724522 |
| 1038 | 96-48-0 | MET | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of MET protein | decreases^expression | 25971889 |
| 1039 | 96-48-0 | PPARG | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA | decreases^expression | 15707987 |
| 1040 | 96-48-0 | PPP1R15A | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA | affects^cotreatment|increases^expression | 17283163 |
| 1041 | 96-48-0 | TOP2A | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of TOP2A protein | decreases^expression | 17089011 |
| 1042 | 96-48-0 | XIAP | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of XIAP protein | decreases^expression | 21442130 |
| 1043 | 96-48-0 | GSTA1 | Mus musculus | angelica lactone results in increased expression of GSTA1 protein | increases^expression | 11309284 |
| 1044 | 96-48-0 | GSTA2 | Mus musculus | angelica lactone results in increased expression of GSTA2 protein | increases^expression | 11309284 |
| 1045 | 96-48-0 | GSTA3 | Mus musculus | angelica lactone results in increased expression of GSTA3 protein | increases^expression | 11309284 |
| 1046 | 96-48-0 | GSTA4 | Mus musculus | angelica lactone results in increased expression of GSTA4 protein | increases^expression | 11309284 |
| 1047 | 96-48-0 | GSTM1 | Mus musculus | angelica lactone results in increased expression of GSTM1 protein | increases^expression | 11309284 |
| 1048 | 96-48-0 | GSTM5 | Mus musculus | angelica lactone results in increased expression of GSTM5 protein | increases^expression | 11309284 |
| 1049 | 96-48-0 | GSTP1 | Mus musculus | angelica lactone results in increased expression of GSTP1 protein | increases^expression | 11309284 |
| 1050 | 96-48-0 | GSTP2 | Mus musculus | angelica lactone results in increased expression of GSTP2 protein | increases^expression | 11309284 |
| 1051 | 96-48-0 | GSTT1 | Rattus norvegicus | angelica lactone results in increased expression of GSTT1 protein | increases^expression | 9855024 |
| 1052 | 96-48-0 | NFE2L2 | Mus musculus | angelica lactone affects the activity of NFE2L2 protein | affects^activity | 11309284 |
| 1053 | 96-48-0 | NQO1 | Mus musculus | angelica lactone results in increased expression of NQO1 protein | increases^expression | 11309284 |
| 1054 | 96-48-0 | NOS2 | Mus musculus | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases^reaction|increases^expression | 12721113 |
| 1055 | 96-48-0 | PTGS2 | Mus musculus | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases^reaction|increases^expression | 12721113 |
| 1056 | 96-48-0 | TNF | Homo sapiens | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF protein] | decreases^reaction|increases^expression | 12721113 |
| 1057 | 96-48-0 | TNF | Mus musculus | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF mRNA] | decreases^reaction|increases^expression | 12721113 |
| 1058 | 96-48-0 | PTGS2 | Rattus norvegicus | L 748706 results in decreased activity of PTGS2 protein | decreases^activity | 15878914 |
| 1059 | 96-48-0 | PTGS2 | Rattus norvegicus | Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] | decreases^activity|increases^reaction | 15878914 |
| 1060 | 96-48-0 | APP | Mus musculus | ligustilide results in decreased expression of APP protein | decreases^expression | 23973442 |
| 1061 | 96-48-0 | CAT | Mus musculus | ligustilide results in increased expression of and results in increased activity of CAT protein | increases^activity|increases^expression | 23973442 |
| 1062 | 96-48-0 | CYP3A4 | Homo sapiens | [ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | increases^activity|increases^expression | 21524698 |
| 1063 | 96-48-0 | HMOX1 | Mus musculus | ligustilide results in increased expression of HMOX1 mRNA | increases^expression | 23441843 |
| 1064 | 96-48-0 | HMOX1 | Mus musculus | ligustilide results in increased expression of HMOX1 protein | increases^expression | 23441843 |
| 1065 | 96-48-0 | KL | Homo sapiens | ligustilide results in increased expression of KL mRNA | increases^expression | 23973442 |
| 1066 | 96-48-0 | KL | Homo sapiens | ligustilide results in increased expression of KL protein | increases^expression | 23973442 |
| 1067 | 96-48-0 | NQO1 | Mus musculus | ligustilide results in increased expression of NQO1 mRNA | increases^expression | 23441843 |
| 1068 | 96-48-0 | NQO1 | Mus musculus | ligustilide results in increased expression of NQO1 protein | increases^expression | 23441843 |
| 1069 | 96-48-0 | NR1I2 | Homo sapiens | ligustilide results in increased activity of NR1I2 protein | increases^activity | 21524698 |
| 1070 | 96-48-0 | SOD2 | Mus musculus | ligustilide results in increased expression of and results in increased activity of SOD2 protein | increases^activity|increases^expression | 23973442 |
| 1071 | 96-48-0 | UGT1A1 | Mus musculus | ligustilide results in increased expression of UGT1A1 protein | increases^expression | 23441843 |
| 1072 | 96-48-0 | ALB | Bos taurus | methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate binds to and affects the folding of ALB protein | affects^binding|affects^folding | 22074127 |
| 1073 | 96-48-0 | CASP3 | Mus musculus | N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP3 protein | increases^activity | 25627690 |
| 1074 | 96-48-0 | CASP7 | Mus musculus | N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein | increases^activity | 25627690 |
| 1075 | 96-48-0 | P2RY2 | Homo sapiens | Ibuprofen inhibits the reaction [N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA] | decreases^expression|decreases^reaction | 10496880 |
| 1076 | 96-48-0 | P2RY2 | Homo sapiens | N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA | decreases^expression | 10496880 |
| 1077 | 96-48-0 | P2RY4 | Homo sapiens | N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY4 mRNA | decreases^expression | 10496880 |
| 1078 | 96-48-0 | PON2 | Homo sapiens | PON2 protein results in increased susceptibility to N-(3-oxododecanoyl)homoserine lactone | increases^response to substance | 25627690 |
| 1079 | 96-48-0 | P2RY2 | Homo sapiens | N-butyrylhomoserine lactone results in decreased expression of P2RY2 mRNA | decreases^expression | 10496880 |
| 1080 | 96-48-0 | P2RY4 | Homo sapiens | N-butyrylhomoserine lactone results in decreased expression of P2RY4 mRNA | decreases^expression | 10496880 |
| 1081 | 96-48-0 | BAX | Homo sapiens | protolichesterinic acid results in increased expression of BAX protein | increases^expression | 22063921 |
| 1082 | 96-48-0 | BCL2 | Homo sapiens | protolichesterinic acid results in decreased expression of BCL2 protein | decreases^expression | 22063921 |
| 1083 | 96-48-0 | CASP3 | Homo sapiens | protolichesterinic acid results in increased activity of CASP3 protein | increases^activity | 22063921 |
| 1084 | 96-48-0 | HSPA1A | Homo sapiens | protolichesterinic acid results in decreased expression of HSPA1A protein | decreases^expression | 22063921 |
| 1085 | 96-48-0 | NOS2 | Homo sapiens | protolichesterinic acid results in decreased expression of NOS2 protein | decreases^expression | 22063921 |
| 1086 | 96-48-0 | TNFSF10 | Homo sapiens | protolichesterinic acid results in increased expression of TNFSF10 protein | increases^expression | 22063921 |
| 1087 | 96-48-0 | CCL2 | spirodiclofen results in decreased expression of CCL2 | decreases^expression | 21788198 | |
| 1088 | 96-48-0 | CXCL10 | spirodiclofen results in increased expression of CXCL10 | increases^expression | 21788198 | |
| 1089 | 96-48-0 | SERPINE1 | spirodiclofen affects the expression of SERPINE1 | affects^expression | 21788198 | |
| 1090 | 96-48-0 | AAAS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1091 | 96-48-0 | ABCC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1092 | 96-48-0 | ABCF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1093 | 96-48-0 | ABCG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1094 | 96-48-0 | ABHD11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1095 | 96-48-0 | ABHD12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1096 | 96-48-0 | ABHD2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA | decreases^expression | 19167446 |
| 1097 | 96-48-0 | ACAA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1098 | 96-48-0 | ACAT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1099 | 96-48-0 | ACBD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1100 | 96-48-0 | ACKR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1101 | 96-48-0 | ACLY | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1102 | 96-48-0 | ACOT4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1103 | 96-48-0 | ACOT7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1104 | 96-48-0 | ACYP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1105 | 96-48-0 | ADAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1106 | 96-48-0 | ADD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1107 | 96-48-0 | AFAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1108 | 96-48-0 | AFF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1109 | 96-48-0 | AGR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1110 | 96-48-0 | AGR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1111 | 96-48-0 | AJUBA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1112 | 96-48-0 | AKAP13 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1113 | 96-48-0 | ALG6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1114 | 96-48-0 | ALG8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1115 | 96-48-0 | AMD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1116 | 96-48-0 | AMMECR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1117 | 96-48-0 | AMOTL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1118 | 96-48-0 | ANLN | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ANLN mRNA | increases^expression | 19167446 |
| 1119 | 96-48-0 | ANLN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1120 | 96-48-0 | ANO6 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA | decreases^expression | 19167446 |
| 1121 | 96-48-0 | ANO6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1122 | 96-48-0 | ANP32E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1123 | 96-48-0 | ANXA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1124 | 96-48-0 | ANXA2P2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2P2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1125 | 96-48-0 | ANXA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1126 | 96-48-0 | ANXA9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1127 | 96-48-0 | AP1B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1128 | 96-48-0 | AP1M1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1129 | 96-48-0 | APBB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1130 | 96-48-0 | APOBEC3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of APOBEC3B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1131 | 96-48-0 | AQP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1132 | 96-48-0 | ARFGEF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1133 | 96-48-0 | ARHGDIA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1134 | 96-48-0 | ARHGEF26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1135 | 96-48-0 | ARHGEF37 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1136 | 96-48-0 | ARL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1137 | 96-48-0 | ARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1138 | 96-48-0 | ARX | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1139 | 96-48-0 | ASF1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1140 | 96-48-0 | ASPM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1141 | 96-48-0 | ATAD2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA | increases^expression | 19167446 |
| 1142 | 96-48-0 | ATAD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1143 | 96-48-0 | ATF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1144 | 96-48-0 | ATF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1145 | 96-48-0 | ATP1B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1146 | 96-48-0 | ATP23 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1147 | 96-48-0 | ATP2B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1148 | 96-48-0 | ATP2C1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1149 | 96-48-0 | ATP5G1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5G1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1150 | 96-48-0 | ATP6V0E1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1151 | 96-48-0 | ATP9A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1152 | 96-48-0 | ATRX | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ATRX mRNA | decreases^expression | 19167446 |
| 1153 | 96-48-0 | ATXN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1154 | 96-48-0 | AURKA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1155 | 96-48-0 | AURKB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1156 | 96-48-0 | AXUD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1157 | 96-48-0 | B3GALNT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1158 | 96-48-0 | B3GNT5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1159 | 96-48-0 | BACE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1160 | 96-48-0 | BACE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1161 | 96-48-0 | BAG3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1162 | 96-48-0 | BARD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1163 | 96-48-0 | BCAR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1164 | 96-48-0 | BCL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1165 | 96-48-0 | BCL2L12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1166 | 96-48-0 | BCL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1167 | 96-48-0 | BCL9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1168 | 96-48-0 | BEX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1169 | 96-48-0 | BHLHE40 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1170 | 96-48-0 | BIRC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1171 | 96-48-0 | BLM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1172 | 96-48-0 | BLNK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1173 | 96-48-0 | BMF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1174 | 96-48-0 | BMP7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1175 | 96-48-0 | BMPR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1176 | 96-48-0 | BRAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1177 | 96-48-0 | BRCA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1178 | 96-48-0 | BRCA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1179 | 96-48-0 | BRI3BP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1180 | 96-48-0 | BRWD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1181 | 96-48-0 | BSDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1182 | 96-48-0 | BSG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1183 | 96-48-0 | BTG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1184 | 96-48-0 | BUB1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1185 | 96-48-0 | C16ORF45 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C16ORF45 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1186 | 96-48-0 | C1ORF112 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1187 | 96-48-0 | C5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1188 | 96-48-0 | C5ORF34 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1189 | 96-48-0 | C9ORF152 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1190 | 96-48-0 | C9ORF40 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1191 | 96-48-0 | CA12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1192 | 96-48-0 | CADM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1193 | 96-48-0 | CALM3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1194 | 96-48-0 | CALU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1195 | 96-48-0 | CAMK2D | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1196 | 96-48-0 | CAMK2N1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1197 | 96-48-0 | CARHSP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1198 | 96-48-0 | CAST | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1199 | 96-48-0 | CBFB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1200 | 96-48-0 | CBLB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1201 | 96-48-0 | CCDC14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1202 | 96-48-0 | CCDC34 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1203 | 96-48-0 | CCNB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1204 | 96-48-0 | CCNB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1205 | 96-48-0 | CCNE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1206 | 96-48-0 | CCNF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1207 | 96-48-0 | CCPG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1208 | 96-48-0 | CD55 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CD55 mRNA | decreases^expression | 19167446 |
| 1209 | 96-48-0 | CD55 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1210 | 96-48-0 | CD59 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1211 | 96-48-0 | CDC25A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1212 | 96-48-0 | CDC25C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1213 | 96-48-0 | CDC27 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1214 | 96-48-0 | CDC45L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1215 | 96-48-0 | CDC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1216 | 96-48-0 | CDC7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1217 | 96-48-0 | CDCA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1218 | 96-48-0 | CDCA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1219 | 96-48-0 | CDCA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1220 | 96-48-0 | CDCA5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1221 | 96-48-0 | CDCA7L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1222 | 96-48-0 | CDCA8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1223 | 96-48-0 | CDH12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1224 | 96-48-0 | CDK1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CDK1 mRNA | increases^expression | 19167446 |
| 1225 | 96-48-0 | CDK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1226 | 96-48-0 | CDK2AP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1227 | 96-48-0 | CDK5RAP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1228 | 96-48-0 | CDKN1A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CDKN1A mRNA | decreases^expression | 19167446 |
| 1229 | 96-48-0 | CDKN1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1230 | 96-48-0 | CDKN2B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1231 | 96-48-0 | CDKN2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1232 | 96-48-0 | CDKN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1233 | 96-48-0 | CDS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1234 | 96-48-0 | CDT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1235 | 96-48-0 | CEBPD | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1236 | 96-48-0 | CELSR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1237 | 96-48-0 | CENPA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1238 | 96-48-0 | CENPF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1239 | 96-48-0 | CENPH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1240 | 96-48-0 | CENPI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1241 | 96-48-0 | CENPL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1242 | 96-48-0 | CENPN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1243 | 96-48-0 | CENPO | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1244 | 96-48-0 | CENPQ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1245 | 96-48-0 | CENPS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1246 | 96-48-0 | CENPU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1247 | 96-48-0 | CENPW | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1248 | 96-48-0 | CEP55 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA | increases^expression | 19167446 |
| 1249 | 96-48-0 | CEP55 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1250 | 96-48-0 | CEP57 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP57 mRNA | increases^expression | 19167446 |
| 1251 | 96-48-0 | CEP78 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1252 | 96-48-0 | CEP85 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1253 | 96-48-0 | CHAC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1254 | 96-48-0 | CHAF1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1255 | 96-48-0 | CHAF1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1256 | 96-48-0 | CHD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1257 | 96-48-0 | CHEK1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CHEK1 mRNA | increases^expression | 19167446 |
| 1258 | 96-48-0 | CHEK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1259 | 96-48-0 | CHEK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1260 | 96-48-0 | CHES1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1261 | 96-48-0 | CHPT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1262 | 96-48-0 | CITED2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1263 | 96-48-0 | CKAP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1264 | 96-48-0 | CKLF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1265 | 96-48-0 | CKS1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1266 | 96-48-0 | CKS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1267 | 96-48-0 | CLDN1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CLDN1 mRNA | decreases^expression | 19167446 |
| 1268 | 96-48-0 | CLDN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1269 | 96-48-0 | CLDN4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1270 | 96-48-0 | CLIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1271 | 96-48-0 | CLN6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1272 | 96-48-0 | CLU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1273 | 96-48-0 | CMC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1274 | 96-48-0 | COL21A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of COL21A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1275 | 96-48-0 | COL5A1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of COL5A1 mRNA | decreases^expression | 19167446 |
| 1276 | 96-48-0 | CRY1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1277 | 96-48-0 | CSE1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1278 | 96-48-0 | CSPG5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1279 | 96-48-0 | CSRNP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1280 | 96-48-0 | CTDSPL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1281 | 96-48-0 | CTNNAL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1282 | 96-48-0 | CTR9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1283 | 96-48-0 | CTTN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1284 | 96-48-0 | CTTNBP2NL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1285 | 96-48-0 | CXXC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1286 | 96-48-0 | CYB5R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1287 | 96-48-0 | CYP19A1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein | decreases^activity | 15876411 |
| 1288 | 96-48-0 | CYP2R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1289 | 96-48-0 | CYR61 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYR61 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1290 | 96-48-0 | DANCR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1291 | 96-48-0 | DARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1292 | 96-48-0 | DBF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1293 | 96-48-0 | DBN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1294 | 96-48-0 | DCAF15 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1295 | 96-48-0 | DCAF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1296 | 96-48-0 | DCAF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1297 | 96-48-0 | DCLK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1298 | 96-48-0 | DCLRE1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1299 | 96-48-0 | DCLRE1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1300 | 96-48-0 | DDAH2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1301 | 96-48-0 | DDB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1302 | 96-48-0 | DDEF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDEF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1303 | 96-48-0 | DDIAS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1304 | 96-48-0 | DDX39B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1305 | 96-48-0 | DEPDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1306 | 96-48-0 | DEPDC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1307 | 96-48-0 | DERA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1308 | 96-48-0 | DHFR | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DHFR mRNA | increases^expression | 19167446 |
| 1309 | 96-48-0 | DHFR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1310 | 96-48-0 | DHRS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1311 | 96-48-0 | DHTKD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1312 | 96-48-0 | DIAPH3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1313 | 96-48-0 | DIP2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1314 | 96-48-0 | DKC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1315 | 96-48-0 | DLGAP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1316 | 96-48-0 | DLX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1317 | 96-48-0 | DMXL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1318 | 96-48-0 | DNAJA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1319 | 96-48-0 | DNAJB9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1320 | 96-48-0 | DNAJC9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1321 | 96-48-0 | DNASE2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DNASE2 mRNA | increases^expression | 19167446 |
| 1322 | 96-48-0 | DNASE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1323 | 96-48-0 | DNM1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1324 | 96-48-0 | DNMT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1325 | 96-48-0 | DONSON | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1326 | 96-48-0 | DSCC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1327 | 96-48-0 | DSCR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DSCR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1328 | 96-48-0 | DSN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1329 | 96-48-0 | DTNA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1330 | 96-48-0 | DUSP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1331 | 96-48-0 | DUT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1332 | 96-48-0 | DYNC1LI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1333 | 96-48-0 | E2F2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1334 | 96-48-0 | E2F5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1335 | 96-48-0 | E2F7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1336 | 96-48-0 | E2F8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1337 | 96-48-0 | EBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1338 | 96-48-0 | ECT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1339 | 96-48-0 | EDIL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1340 | 96-48-0 | EED | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1341 | 96-48-0 | EEF1A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1342 | 96-48-0 | EFEMP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1343 | 96-48-0 | EFHD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1344 | 96-48-0 | EFNA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1345 | 96-48-0 | EFNB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1346 | 96-48-0 | EGR1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA | decreases^expression | 19167446 |
| 1347 | 96-48-0 | EGR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1348 | 96-48-0 | EGR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1349 | 96-48-0 | ELF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1350 | 96-48-0 | ELK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1351 | 96-48-0 | ELOVL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1352 | 96-48-0 | ELOVL6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1353 | 96-48-0 | ELOVL7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1354 | 96-48-0 | ELP6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1355 | 96-48-0 | EMC9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1356 | 96-48-0 | EME1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1357 | 96-48-0 | ENC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1358 | 96-48-0 | ENDOD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1359 | 96-48-0 | ENOSF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENOSF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1360 | 96-48-0 | EPB41L5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1361 | 96-48-0 | EPHA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1362 | 96-48-0 | EPS15L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1363 | 96-48-0 | ERCC6L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1364 | 96-48-0 | ERI2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1365 | 96-48-0 | ERRFI1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ERRFI1 mRNA | decreases^expression | 19167446 |
| 1366 | 96-48-0 | ERRFI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1367 | 96-48-0 | ESPL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1368 | 96-48-0 | EXO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1369 | 96-48-0 | EXOC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1370 | 96-48-0 | EXT1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA | decreases^expression | 19167446 |
| 1371 | 96-48-0 | EXT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1372 | 96-48-0 | EZH2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1373 | 96-48-0 | EZR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1374 | 96-48-0 | F2RL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1375 | 96-48-0 | FAM107B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1376 | 96-48-0 | FAM110B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1377 | 96-48-0 | FAM111A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1378 | 96-48-0 | FAM149B1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1379 | 96-48-0 | FAM189A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1380 | 96-48-0 | FAM214A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1381 | 96-48-0 | FAM43A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA | decreases^expression | 19167446 |
| 1382 | 96-48-0 | FAM43A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1383 | 96-48-0 | FAM49B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM49B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1384 | 96-48-0 | FANCD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1385 | 96-48-0 | FANCG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1386 | 96-48-0 | FANCI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1387 | 96-48-0 | FANCL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1388 | 96-48-0 | FBXO38 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1389 | 96-48-0 | FBXO5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1390 | 96-48-0 | FCMR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1391 | 96-48-0 | FDFT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1392 | 96-48-0 | FEN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1393 | 96-48-0 | FERMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1394 | 96-48-0 | FIBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1395 | 96-48-0 | FIGNL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1396 | 96-48-0 | FILIP1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1397 | 96-48-0 | FKBP11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1398 | 96-48-0 | FKBP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1399 | 96-48-0 | FLCN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1400 | 96-48-0 | FNBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1401 | 96-48-0 | FNBP1L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1402 | 96-48-0 | FOS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1403 | 96-48-0 | FOXM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1404 | 96-48-0 | FOXO3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1405 | 96-48-0 | FOXP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1406 | 96-48-0 | FRMD6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1407 | 96-48-0 | FSCN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1408 | 96-48-0 | FYCO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1409 | 96-48-0 | G2E3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1410 | 96-48-0 | G3BP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1411 | 96-48-0 | GABPB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1412 | 96-48-0 | GADD45A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GADD45A mRNA | decreases^expression | 19167446 |
| 1413 | 96-48-0 | GADD45A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1414 | 96-48-0 | GALNS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1415 | 96-48-0 | GALNT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1416 | 96-48-0 | GALNT10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1417 | 96-48-0 | GALNT7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1418 | 96-48-0 | GANAB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1419 | 96-48-0 | GAS2L3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1420 | 96-48-0 | GATA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1421 | 96-48-0 | GBP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1422 | 96-48-0 | GCHFR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1423 | 96-48-0 | GDF15 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1424 | 96-48-0 | GDPD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1425 | 96-48-0 | GEMIN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1426 | 96-48-0 | GFRA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1427 | 96-48-0 | GGCT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1428 | 96-48-0 | GGH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1429 | 96-48-0 | GINS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1430 | 96-48-0 | GINS2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of GINS2 mRNA | increases^expression | 19167446 |
| 1431 | 96-48-0 | GINS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1432 | 96-48-0 | GINS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1433 | 96-48-0 | GINS4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1434 | 96-48-0 | GLE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1435 | 96-48-0 | GMNN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1436 | 96-48-0 | GMPS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1437 | 96-48-0 | GNAS | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA | decreases^expression | 19167446 |
| 1438 | 96-48-0 | GOLGA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1439 | 96-48-0 | GOT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1440 | 96-48-0 | GPAA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1441 | 96-48-0 | GPAT4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1442 | 96-48-0 | GPRC5A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1443 | 96-48-0 | GPRC5C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1444 | 96-48-0 | GPSM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1445 | 96-48-0 | GPSN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSN2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1446 | 96-48-0 | GRAMD1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1447 | 96-48-0 | GREB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1448 | 96-48-0 | GRHL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1449 | 96-48-0 | GTF2IRD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1450 | 96-48-0 | GTSE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1451 | 96-48-0 | GULP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1452 | 96-48-0 | H2AFV | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFV mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1453 | 96-48-0 | H2AFX | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1454 | 96-48-0 | H2AFZ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFZ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1455 | 96-48-0 | H3F3B | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of H3F3B mRNA | decreases^expression | 19167446 |
| 1456 | 96-48-0 | H3F3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3F3B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1457 | 96-48-0 | HADH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1458 | 96-48-0 | HAUS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1459 | 96-48-0 | HAUS4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1460 | 96-48-0 | HEBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1461 | 96-48-0 | HELLS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1462 | 96-48-0 | HELZ2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1463 | 96-48-0 | HERC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1464 | 96-48-0 | HES1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HES1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1465 | 96-48-0 | HIRIP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1466 | 96-48-0 | HIST1H1C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H1C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1467 | 96-48-0 | HIST1H2AC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1468 | 96-48-0 | HIST1H2AE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AE mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1469 | 96-48-0 | HIST1H2BC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1470 | 96-48-0 | HIST1H2BD | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BD mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1471 | 96-48-0 | HIST1H2BG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BG mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1472 | 96-48-0 | HIST1H2BH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BH mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1473 | 96-48-0 | HIST1H3D | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3D mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1474 | 96-48-0 | HIST1H3H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3H mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1475 | 96-48-0 | HIST1H4H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H4H mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1476 | 96-48-0 | HIST2H2BE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST2H2BE mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1477 | 96-48-0 | HIST3H2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST3H2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1478 | 96-48-0 | HJURP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1479 | 96-48-0 | HMGA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1480 | 96-48-0 | HMGB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1481 | 96-48-0 | HMGB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1482 | 96-48-0 | HMGN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGN3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1483 | 96-48-0 | HMMR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMMR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1484 | 96-48-0 | HNRNPH1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HNRNPH1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1485 | 96-48-0 | HOXC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HOXC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1486 | 96-48-0 | HPRT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HPRT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1487 | 96-48-0 | HS6ST2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HS6ST2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1488 | 96-48-0 | HSD17B1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of HSD17B1 protein | decreases^activity | 15876411 |
| 1489 | 96-48-0 | HSD17B6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1490 | 96-48-0 | HSPA4L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSPA4L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1491 | 96-48-0 | HYLS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HYLS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1492 | 96-48-0 | ICA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1493 | 96-48-0 | ICE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1494 | 96-48-0 | ICMT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1495 | 96-48-0 | ID3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ID3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1496 | 96-48-0 | IDS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IDS mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1497 | 96-48-0 | IER2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1498 | 96-48-0 | IER5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1499 | 96-48-0 | IFI44L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFI44L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1500 | 96-48-0 | IFIT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFIT2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1501 | 96-48-0 | IFRD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1502 | 96-48-0 | IFT122 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT122 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1503 | 96-48-0 | IFT20 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT20 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1504 | 96-48-0 | IFT43 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT43 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1505 | 96-48-0 | IGFBP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1506 | 96-48-0 | IGFBP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1507 | 96-48-0 | IGFBP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1508 | 96-48-0 | IGFLR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFLR1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1509 | 96-48-0 | IL1R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IL1R1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1510 | 96-48-0 | IL20 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IL20 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1511 | 96-48-0 | ILF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1512 | 96-48-0 | ILVBL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILVBL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1513 | 96-48-0 | INCENP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1514 | 96-48-0 | INHBB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of INHBB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1515 | 96-48-0 | INO80E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INO80E mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1516 | 96-48-0 | INSIG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1517 | 96-48-0 | IP6K2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1518 | 96-48-0 | IQCK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IQCK mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1519 | 96-48-0 | IQGAP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1520 | 96-48-0 | IRF6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1521 | 96-48-0 | IRF9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1522 | 96-48-0 | IRS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1523 | 96-48-0 | ISYNA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ISYNA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1524 | 96-48-0 | ITGA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITGA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1525 | 96-48-0 | ITGAE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGAE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1526 | 96-48-0 | ITGB3BP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGB3BP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1527 | 96-48-0 | ITPR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITPR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1528 | 96-48-0 | JAG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JAG1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1529 | 96-48-0 | JMY | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JMY mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1530 | 96-48-0 | JUN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1531 | 96-48-0 | JUNB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUNB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1532 | 96-48-0 | KDM4B | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM4B mRNA | decreases^expression | 19167446 |
| 1533 | 96-48-0 | KDM5A | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA | decreases^expression | 19167446 |
| 1534 | 96-48-0 | KDM5B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1535 | 96-48-0 | KDR | Mus musculus | 2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] | decreases^reaction|increases^expression | 17289903 |
| 1536 | 96-48-0 | KIAA0100 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1537 | 96-48-0 | KIAA0513 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1538 | 96-48-0 | KIAA1147 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1147 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1539 | 96-48-0 | KIAA1211 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1211 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1540 | 96-48-0 | KIDINS220 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIDINS220 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1541 | 96-48-0 | KIF11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1542 | 96-48-0 | KIF14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1543 | 96-48-0 | KIF18A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1544 | 96-48-0 | KIF20A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF20A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1545 | 96-48-0 | KIF2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1546 | 96-48-0 | KIF5C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIF5C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1547 | 96-48-0 | KIFC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIFC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1548 | 96-48-0 | KLF12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF12 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1549 | 96-48-0 | KLF6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1550 | 96-48-0 | KLF9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1551 | 96-48-0 | KLHDC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KLHDC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1552 | 96-48-0 | KLHL24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL24 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1553 | 96-48-0 | KLHL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1554 | 96-48-0 | KMT2E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KMT2E mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1555 | 96-48-0 | KNSTRN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1556 | 96-48-0 | KNTC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNTC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1557 | 96-48-0 | KPNA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KPNA4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1558 | 96-48-0 | KRT80 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KRT80 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1559 | 96-48-0 | L1CAM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1560 | 96-48-0 | L2HGDH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1561 | 96-48-0 | LAGE3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LAGE3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1562 | 96-48-0 | LARP6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LARP6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1563 | 96-48-0 | LCMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1564 | 96-48-0 | LDLR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LDLR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1565 | 96-48-0 | LEPR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1566 | 96-48-0 | LGALS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1567 | 96-48-0 | LIG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LIG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1568 | 96-48-0 | LINC00052 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LINC00052 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1569 | 96-48-0 | LMNB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1570 | 96-48-0 | LMNB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1571 | 96-48-0 | LRIG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1572 | 96-48-0 | LRR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRR1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1573 | 96-48-0 | LSM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LSM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1574 | 96-48-0 | MAD2L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAD2L1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1575 | 96-48-0 | MAFF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1576 | 96-48-0 | MAGI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAGI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1577 | 96-48-0 | MALAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MALAT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1578 | 96-48-0 | MAP1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1579 | 96-48-0 | MAP4K4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1580 | 96-48-0 | MAST4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1581 | 96-48-0 | MASTL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MASTL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1582 | 96-48-0 | MATN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1583 | 96-48-0 | MAZ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAZ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1584 | 96-48-0 | MB21D2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MB21D2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1585 | 96-48-0 | MCAM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCAM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1586 | 96-48-0 | MCM10 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of MCM10 mRNA | increases^expression | 19167446 |
| 1587 | 96-48-0 | MCM10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1588 | 96-48-0 | MCM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1589 | 96-48-0 | MCM3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1590 | 96-48-0 | MCM4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1591 | 96-48-0 | MCM5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1592 | 96-48-0 | MCM6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1593 | 96-48-0 | MCM7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1594 | 96-48-0 | MCM8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1595 | 96-48-0 | MCUB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1596 | 96-48-0 | MDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MDC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1597 | 96-48-0 | MEA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1598 | 96-48-0 | MEAF6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEAF6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1599 | 96-48-0 | MEF2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1600 | 96-48-0 | MELK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MELK mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1601 | 96-48-0 | MEPCE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEPCE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1602 | 96-48-0 | METAP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of METAP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1603 | 96-48-0 | METTL7A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of METTL7A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1604 | 96-48-0 | MGAT4B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGAT4B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1605 | 96-48-0 | MGLL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1606 | 96-48-0 | MGP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MGP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1607 | 96-48-0 | MIR21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MIR21 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1608 | 96-48-0 | MIS18BP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1609 | 96-48-0 | MKI67 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1610 | 96-48-0 | MKNK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1611 | 96-48-0 | MLH1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1612 | 96-48-0 | MOAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MOAP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1613 | 96-48-0 | MPHOSPH9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1614 | 96-48-0 | MRE11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1615 | 96-48-0 | MRM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1616 | 96-48-0 | MRPL37 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1617 | 96-48-0 | MRPS26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS26 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1618 | 96-48-0 | MRPS27 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS27 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1619 | 96-48-0 | MSH6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MSH6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1620 | 96-48-0 | MTCP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTCP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1621 | 96-48-0 | MTFP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTFP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1622 | 96-48-0 | MTHFD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTHFD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1623 | 96-48-0 | MTMR4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTMR4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1624 | 96-48-0 | MTUS1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of MTUS1 mRNA | decreases^expression | 19167446 |
| 1625 | 96-48-0 | MTUS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MTUS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1626 | 96-48-0 | MVP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MVP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1627 | 96-48-0 | MXD4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1628 | 96-48-0 | MYB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1629 | 96-48-0 | MYBL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYBL2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1630 | 96-48-0 | MYCBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYCBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1631 | 96-48-0 | MYLIP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1632 | 96-48-0 | MYO1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO1B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1633 | 96-48-0 | MYO5A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1634 | 96-48-0 | MYO5B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1635 | 96-48-0 | MYO6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1636 | 96-48-0 | MZT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MZT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1637 | 96-48-0 | N4BP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1638 | 96-48-0 | NAA50 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NAA50 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1639 | 96-48-0 | NANOS1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of NANOS1 mRNA | decreases^expression | 19167446 |
| 1640 | 96-48-0 | NANOS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NANOS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1641 | 96-48-0 | NASP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1642 | 96-48-0 | NBEA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1643 | 96-48-0 | NBEAL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEAL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1644 | 96-48-0 | NBPF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1645 | 96-48-0 | NCAPG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1646 | 96-48-0 | NCAPG2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1647 | 96-48-0 | NCOA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1648 | 96-48-0 | NCOA7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1649 | 96-48-0 | NDC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1650 | 96-48-0 | NDE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1651 | 96-48-0 | NDFIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NDFIP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1652 | 96-48-0 | NEAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEAT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1653 | 96-48-0 | NEBL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEBL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1654 | 96-48-0 | NEDD4L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD4L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1655 | 96-48-0 | NEDD9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1656 | 96-48-0 | NEIL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1657 | 96-48-0 | NEURL1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1658 | 96-48-0 | NFATC2IP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1659 | 96-48-0 | NFIL3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1660 | 96-48-0 | NINL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NINL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1661 | 96-48-0 | NMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1662 | 96-48-0 | NMU | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NMU mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1663 | 96-48-0 | NOM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NOM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1664 | 96-48-0 | NPAS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPAS3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1665 | 96-48-0 | NPEPPS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPEPPS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1666 | 96-48-0 | NPHP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPHP3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1667 | 96-48-0 | NPNT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPNT mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1668 | 96-48-0 | NPY1R | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPY1R mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1669 | 96-48-0 | NQO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NQO1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1670 | 96-48-0 | NQO2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1671 | 96-48-0 | NR1I2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased activity of NR1I2 protein | increases^activity | 15885729 |
| 1672 | 96-48-0 | NR2F6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NR2F6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1673 | 96-48-0 | NR4A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1674 | 96-48-0 | NRCAM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NRCAM mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1675 | 96-48-0 | NRM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1676 | 96-48-0 | NSD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NSD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1677 | 96-48-0 | NT5E | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1678 | 96-48-0 | NTN4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NTN4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1679 | 96-48-0 | NUAK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NUAK1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1680 | 96-48-0 | NUDT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUDT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1681 | 96-48-0 | NUP107 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1682 | 96-48-0 | NUP155 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1683 | 96-48-0 | NUP210 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1684 | 96-48-0 | NUP62CL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1685 | 96-48-0 | NUSAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1686 | 96-48-0 | OAZ2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OAZ2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1687 | 96-48-0 | ODF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ODF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1688 | 96-48-0 | OIP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OIP5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1689 | 96-48-0 | OLFM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1690 | 96-48-0 | OPTN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OPTN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1691 | 96-48-0 | ORC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1692 | 96-48-0 | ORC6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1693 | 96-48-0 | OSBPL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSBPL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1694 | 96-48-0 | OSER1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1695 | 96-48-0 | OTUD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OTUD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1696 | 96-48-0 | OXCT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1697 | 96-48-0 | OXTR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OXTR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1698 | 96-48-0 | P4HB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of P4HB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1699 | 96-48-0 | PAICS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PAICS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1700 | 96-48-0 | PAPSS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAPSS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1701 | 96-48-0 | PARP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1702 | 96-48-0 | PARP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1703 | 96-48-0 | PARPBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARPBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1704 | 96-48-0 | PARVA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PARVA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1705 | 96-48-0 | PAWR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1706 | 96-48-0 | PBK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PBK mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1707 | 96-48-0 | PCK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1708 | 96-48-0 | PCLAF | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA | increases^expression | 19167446 |
| 1709 | 96-48-0 | PCLAF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1710 | 96-48-0 | PCMTD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1711 | 96-48-0 | PCNA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1712 | 96-48-0 | PCNT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1713 | 96-48-0 | PCSK6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCSK6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1714 | 96-48-0 | PCTK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1715 | 96-48-0 | PDCD4 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PDCD4 mRNA | increases^expression | 19167446 |
| 1716 | 96-48-0 | PDCD6IP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDCD6IP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1717 | 96-48-0 | PDIA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1718 | 96-48-0 | PDIA6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1719 | 96-48-0 | PDLIM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDLIM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1720 | 96-48-0 | PDZK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDZK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1721 | 96-48-0 | PFKL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PFKL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1722 | 96-48-0 | PGGT1B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGGT1B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1723 | 96-48-0 | PGM2L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM2L1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1724 | 96-48-0 | PGM3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1725 | 96-48-0 | PGRMC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PGRMC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1726 | 96-48-0 | PGRMC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGRMC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1727 | 96-48-0 | PHACTR2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1728 | 96-48-0 | PHF19 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PHF19 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1729 | 96-48-0 | PHF20L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHF20L1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1730 | 96-48-0 | PHLDA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1731 | 96-48-0 | PHLDB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1732 | 96-48-0 | PIK3C3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PIK3C3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1733 | 96-48-0 | PIMREG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1734 | 96-48-0 | PKIB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKIB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1735 | 96-48-0 | PKM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1736 | 96-48-0 | PKMYT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1737 | 96-48-0 | PLCXD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1738 | 96-48-0 | PLEKHA5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHA5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1739 | 96-48-0 | PLEKHB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1740 | 96-48-0 | PLK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1741 | 96-48-0 | PLK4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1742 | 96-48-0 | PLOD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLOD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1743 | 96-48-0 | PMEPA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMEPA1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1744 | 96-48-0 | PMPCB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMPCB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1745 | 96-48-0 | PNP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PNP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1746 | 96-48-0 | POLA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1747 | 96-48-0 | POLA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1748 | 96-48-0 | POLD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1749 | 96-48-0 | POLD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1750 | 96-48-0 | POLD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1751 | 96-48-0 | POLE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1752 | 96-48-0 | POLE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1753 | 96-48-0 | POLE3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1754 | 96-48-0 | PPAT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPAT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1755 | 96-48-0 | PPIF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPIF mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1756 | 96-48-0 | PPL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1757 | 96-48-0 | PPP1R10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPP1R10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1758 | 96-48-0 | PPP2R2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1759 | 96-48-0 | PPP2R3A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R3A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1760 | 96-48-0 | PPP3CC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP3CC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1761 | 96-48-0 | PRDX4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRDX4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1762 | 96-48-0 | PREX1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PREX1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1763 | 96-48-0 | PRIM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1764 | 96-48-0 | PRIM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1765 | 96-48-0 | PRKDC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1766 | 96-48-0 | PRPF4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRPF4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1767 | 96-48-0 | PRR14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRR14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1768 | 96-48-0 | PRRC2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1769 | 96-48-0 | PRRC2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRC2C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1770 | 96-48-0 | PRRT3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRT3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1771 | 96-48-0 | PRSS23 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of PRSS23 mRNA | decreases^expression | 19167446 |
| 1772 | 96-48-0 | PRSS23 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRSS23 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1773 | 96-48-0 | PSIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSIP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1774 | 96-48-0 | PSMC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSMC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1775 | 96-48-0 | PSRC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSRC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1776 | 96-48-0 | PTBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1777 | 96-48-0 | PTGES | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTGES mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1778 | 96-48-0 | PTP4A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTP4A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1779 | 96-48-0 | PTPN12 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN12 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1780 | 96-48-0 | PTPN21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN21 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1781 | 96-48-0 | PTTG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTTG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1782 | 96-48-0 | PUS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PUS3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1783 | 96-48-0 | PYROXD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1784 | 96-48-0 | QSER1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of QSER1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1785 | 96-48-0 | RAB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1786 | 96-48-0 | RAB31 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB31 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1787 | 96-48-0 | RAB32 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB32 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1788 | 96-48-0 | RAB40B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1789 | 96-48-0 | RAB8A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB8A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1790 | 96-48-0 | RACGAP1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA | increases^expression | 19167446 |
| 1791 | 96-48-0 | RACGAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1792 | 96-48-0 | RAD21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD21 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1793 | 96-48-0 | RAD51 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1794 | 96-48-0 | RAD51AP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1795 | 96-48-0 | RAD51C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1796 | 96-48-0 | RAD54B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1797 | 96-48-0 | RAD54L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1798 | 96-48-0 | RANBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1799 | 96-48-0 | RANGAP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANGAP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1800 | 96-48-0 | RAPGEF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1801 | 96-48-0 | RAPGEFL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAPGEFL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1802 | 96-48-0 | RASD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASD1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1803 | 96-48-0 | RASEF | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1804 | 96-48-0 | RASL11B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1805 | 96-48-0 | RASSF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASSF3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1806 | 96-48-0 | RAVER1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1807 | 96-48-0 | RB1CC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1808 | 96-48-0 | RBBP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1809 | 96-48-0 | RBBP8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1810 | 96-48-0 | RBBP9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1811 | 96-48-0 | RBFOX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1812 | 96-48-0 | RBM10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1813 | 96-48-0 | RBM15 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM15 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1814 | 96-48-0 | RBMS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1815 | 96-48-0 | RCCD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RCCD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1816 | 96-48-0 | RCOR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RCOR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1817 | 96-48-0 | RDM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RDM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1818 | 96-48-0 | RECQL4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RECQL4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1819 | 96-48-0 | REEP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of REEP3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1820 | 96-48-0 | REEP5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1821 | 96-48-0 | RERG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RERG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1822 | 96-48-0 | RET | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RET mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1823 | 96-48-0 | RFC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1824 | 96-48-0 | RFC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1825 | 96-48-0 | RFC4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1826 | 96-48-0 | RFC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1827 | 96-48-0 | RFTN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1828 | 96-48-0 | RGS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RGS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1829 | 96-48-0 | RHBDF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1830 | 96-48-0 | RHNO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RHNO1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1831 | 96-48-0 | RHOQ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOQ mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1832 | 96-48-0 | RHOT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1833 | 96-48-0 | RMDN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RMDN2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1834 | 96-48-0 | RMI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1835 | 96-48-0 | RMI2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA | increases^expression | 19167446 |
| 1836 | 96-48-0 | RMI2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1837 | 96-48-0 | RNASEH2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNASEH2A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1838 | 96-48-0 | RNF187 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF187 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1839 | 96-48-0 | RNF19A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RNF19A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1840 | 96-48-0 | RNF26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1841 | 96-48-0 | ROCK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1842 | 96-48-0 | RPA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1843 | 96-48-0 | RPA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1844 | 96-48-0 | RPL39L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPL39L mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1845 | 96-48-0 | RRAGC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RRAGC mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1846 | 96-48-0 | RRM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1847 | 96-48-0 | RRM2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1848 | 96-48-0 | RSRC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1849 | 96-48-0 | RSU1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1850 | 96-48-0 | RUNDC3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RUNDC3B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1851 | 96-48-0 | S100A10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1852 | 96-48-0 | S1PR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1853 | 96-48-0 | SAE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SAE1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1854 | 96-48-0 | SALL4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SALL4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1855 | 96-48-0 | SASH1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SASH1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1856 | 96-48-0 | SAT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SAT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1857 | 96-48-0 | SCARB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SCARB1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1858 | 96-48-0 | SCARB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCARB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1859 | 96-48-0 | SCCPDH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCCPDH mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1860 | 96-48-0 | SELENOP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SELENOP mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1861 | 96-48-0 | SEPHS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SEPHS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1862 | 96-48-0 | SERINC5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1863 | 96-48-0 | SF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1864 | 96-48-0 | SF3B3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF3B3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1865 | 96-48-0 | SFN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1866 | 96-48-0 | SFXN2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1867 | 96-48-0 | SGCG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SGCG mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1868 | 96-48-0 | SGK3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1869 | 96-48-0 | SGO1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1870 | 96-48-0 | SGO2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1871 | 96-48-0 | SH3BGRL | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SH3BGRL mRNA | decreases^expression | 19167446 |
| 1872 | 96-48-0 | SH3BGRL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BGRL mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1873 | 96-48-0 | SH3BP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BP4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1874 | 96-48-0 | SH3KBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3KBP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1875 | 96-48-0 | SHCBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1876 | 96-48-0 | SHISA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SHISA2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1877 | 96-48-0 | SHMT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1878 | 96-48-0 | SHMT2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1879 | 96-48-0 | SKA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1880 | 96-48-0 | SKA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1881 | 96-48-0 | SKA3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1882 | 96-48-0 | SKP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1883 | 96-48-0 | SLBP | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1884 | 96-48-0 | SLC12A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1885 | 96-48-0 | SLC12A4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1886 | 96-48-0 | SLC12A8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1887 | 96-48-0 | SLC1A4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC1A4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1888 | 96-48-0 | SLC25A11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A11 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1889 | 96-48-0 | SLC25A39 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A39 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1890 | 96-48-0 | SLC26A11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1891 | 96-48-0 | SLC27A2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1892 | 96-48-0 | SLC27A3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1893 | 96-48-0 | SLC29A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1894 | 96-48-0 | SLC2A4RG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1895 | 96-48-0 | SLC35D2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC35D2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1896 | 96-48-0 | SLC37A4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC37A4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1897 | 96-48-0 | SLC39A8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1898 | 96-48-0 | SLC6A14 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC6A14 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1899 | 96-48-0 | SLC7A1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1900 | 96-48-0 | SLC7A11 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA | decreases^expression | 19167446 |
| 1901 | 96-48-0 | SLC7A11 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1902 | 96-48-0 | SLC7A5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1903 | 96-48-0 | SLC9A3R1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC9A3R1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1904 | 96-48-0 | SLF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1905 | 96-48-0 | SMAD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1906 | 96-48-0 | SMAD3 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SMAD3 mRNA | decreases^expression | 19167446 |
| 1907 | 96-48-0 | SMAD3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1908 | 96-48-0 | SMC1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC1A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1909 | 96-48-0 | SMC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1910 | 96-48-0 | SMC4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1911 | 96-48-0 | SMYD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMYD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1912 | 96-48-0 | SNHG7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNHG7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1913 | 96-48-0 | SNN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNN mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1914 | 96-48-0 | SNORA24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORA24 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1915 | 96-48-0 | SNORD52 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORD52 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1916 | 96-48-0 | SNRNP25 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRNP25 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1917 | 96-48-0 | SNRPA1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPA1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1918 | 96-48-0 | SNRPB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1919 | 96-48-0 | SNX10 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1920 | 96-48-0 | SNX24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1921 | 96-48-0 | SNX29 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1922 | 96-48-0 | SNX6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1923 | 96-48-0 | SNX9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1924 | 96-48-0 | SOCS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1925 | 96-48-0 | SOX3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SOX3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1926 | 96-48-0 | SOX4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1927 | 96-48-0 | SOX9 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1928 | 96-48-0 | SPAG5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1929 | 96-48-0 | SPATA7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1930 | 96-48-0 | SPC24 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1931 | 96-48-0 | SPC25 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1932 | 96-48-0 | SPDL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPDL1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1933 | 96-48-0 | SPIN4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPIN4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1934 | 96-48-0 | SPRED2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1935 | 96-48-0 | SQOR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQOR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1936 | 96-48-0 | SQSTM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1937 | 96-48-0 | SRD5A3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRD5A3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1938 | 96-48-0 | SRI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SRI mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1939 | 96-48-0 | SRM | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRM mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1940 | 96-48-0 | SRPRB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1941 | 96-48-0 | SRSF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1942 | 96-48-0 | SSBP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1943 | 96-48-0 | SSRP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SSRP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1944 | 96-48-0 | ST8SIA4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ST8SIA4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1945 | 96-48-0 | STIL | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1946 | 96-48-0 | STK38L | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STK38L mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1947 | 96-48-0 | STMN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STMN1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1948 | 96-48-0 | STON2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1949 | 96-48-0 | STRN3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STRN3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1950 | 96-48-0 | STX3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1951 | 96-48-0 | STX7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1952 | 96-48-0 | SULF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1953 | 96-48-0 | SUPT16H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUPT16H mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1954 | 96-48-0 | SUV39H2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1955 | 96-48-0 | SWAP70 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1956 | 96-48-0 | SYCE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1957 | 96-48-0 | SYDE2 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SYDE2 mRNA | decreases^expression | 19167446 |
| 1958 | 96-48-0 | SYDE2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYDE2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1959 | 96-48-0 | SYNGR3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1960 | 96-48-0 | SYTL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1961 | 96-48-0 | SYTL4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1962 | 96-48-0 | SYTL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1963 | 96-48-0 | TACC3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1964 | 96-48-0 | TACSTD2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1965 | 96-48-0 | TAF5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1966 | 96-48-0 | TANC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1967 | 96-48-0 | TAOK3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1968 | 96-48-0 | TARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1969 | 96-48-0 | TBCD | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TBCD mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1970 | 96-48-0 | TBL1X | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TBL1X mRNA | decreases^expression | 19167446 |
| 1971 | 96-48-0 | TCF19 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA | increases^expression | 19167446 |
| 1972 | 96-48-0 | TCF19 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1973 | 96-48-0 | TCF7L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TCF7L1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1974 | 96-48-0 | TDP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TDP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1975 | 96-48-0 | TEX30 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TEX30 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1976 | 96-48-0 | TFAP2C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1977 | 96-48-0 | TFDP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFDP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1978 | 96-48-0 | TFF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1979 | 96-48-0 | TFF3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1980 | 96-48-0 | TFPI | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1981 | 96-48-0 | TGFB2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1982 | 96-48-0 | TGFBR1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFBR1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1983 | 96-48-0 | TGIF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGIF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1984 | 96-48-0 | TGIF2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TGIF2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1985 | 96-48-0 | THBS1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THBS1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1986 | 96-48-0 | THEM6 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THEM6 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1987 | 96-48-0 | THSD4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1988 | 96-48-0 | TICRR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TICRR mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1989 | 96-48-0 | TIGAR | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIGAR mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1990 | 96-48-0 | TIMELESS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1991 | 96-48-0 | TIMP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIMP2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1992 | 96-48-0 | TIPIN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1993 | 96-48-0 | TK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1994 | 96-48-0 | TKFC | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1995 | 96-48-0 | TLE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TLE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1996 | 96-48-0 | TM4SF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1997 | 96-48-0 | TMCC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMCC1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 1998 | 96-48-0 | TMED8 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMED8 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 1999 | 96-48-0 | TMEM106C | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM106C mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2000 | 96-48-0 | TMEM164 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM164 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2001 | 96-48-0 | TMEM237 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM237 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2002 | 96-48-0 | TMEM38B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2003 | 96-48-0 | TMEM45B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2004 | 96-48-0 | TMEM64 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2005 | 96-48-0 | TMEM65 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2006 | 96-48-0 | TMEM97 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2007 | 96-48-0 | TMPO | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2008 | 96-48-0 | TMPRSS3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPRSS3 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2009 | 96-48-0 | TMSB15A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMSB15A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2010 | 96-48-0 | TMTC2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMTC2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2011 | 96-48-0 | TNFAIP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2012 | 96-48-0 | TNFRSF12A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF12A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2013 | 96-48-0 | TNFRSF21 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF21 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2014 | 96-48-0 | TOP2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOP2A mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2015 | 96-48-0 | TOPBP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOPBP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2016 | 96-48-0 | TP53INP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TP53INP1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2017 | 96-48-0 | TPD52 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2018 | 96-48-0 | TPD52L1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPD52L1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2019 | 96-48-0 | TPI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPI1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2020 | 96-48-0 | TPM1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPM1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2021 | 96-48-0 | TPX2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPX2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2022 | 96-48-0 | TRERF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRERF1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2023 | 96-48-0 | TRIB1 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA | decreases^expression | 19167446 |
| 2024 | 96-48-0 | TRIB1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2025 | 96-48-0 | TRIM59 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIM59 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2026 | 96-48-0 | TRIP13 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2027 | 96-48-0 | TSC22D3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSC22D3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2028 | 96-48-0 | TSN | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TSN mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2029 | 96-48-0 | TSPAN31 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPAN31 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2030 | 96-48-0 | TSPYL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPYL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2031 | 96-48-0 | TTC39B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2032 | 96-48-0 | TTK | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA | increases^expression | 19167446 |
| 2033 | 96-48-0 | TTK | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2034 | 96-48-0 | TUBA2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBA2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2035 | 96-48-0 | TUBB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2036 | 96-48-0 | TUBB2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUBB2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2037 | 96-48-0 | TUBB4B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2038 | 96-48-0 | TUBD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2039 | 96-48-0 | TUBG1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBG1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2040 | 96-48-0 | TUBGCP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBGCP4 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2041 | 96-48-0 | TUFT1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUFT1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2042 | 96-48-0 | TULP4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TULP4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2043 | 96-48-0 | TWIST1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2044 | 96-48-0 | TYMS | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TYMS mRNA | increases^expression | 19167446 |
| 2045 | 96-48-0 | TYMS | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TYMS mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2046 | 96-48-0 | UBE2B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2047 | 96-48-0 | UBE2H | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2H mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2048 | 96-48-0 | UBE2J1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2049 | 96-48-0 | UBE2QL1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2QL1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2050 | 96-48-0 | UBE2T | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBE2T mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2051 | 96-48-0 | UBE2W | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2052 | 96-48-0 | UBR7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBR7 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2053 | 96-48-0 | UCHL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2054 | 96-48-0 | UCK2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2055 | 96-48-0 | UHRF1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UHRF1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2056 | 96-48-0 | UNG | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UNG mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2057 | 96-48-0 | UPF3B | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UPF3B mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2058 | 96-48-0 | USP1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2059 | 96-48-0 | USP3 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of USP3 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2060 | 96-48-0 | UST | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2061 | 96-48-0 | VARS2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2062 | 96-48-0 | VEGFA | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of VEGFA mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2063 | 96-48-0 | VKORC1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2064 | 96-48-0 | VRK1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2065 | 96-48-0 | WDHD1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDHD1 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2066 | 96-48-0 | WDR34 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR34 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2067 | 96-48-0 | WDR54 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR54 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2068 | 96-48-0 | WDR76 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR76 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2069 | 96-48-0 | WIPI1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of WIPI1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2070 | 96-48-0 | WISP2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WISP2 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2071 | 96-48-0 | WIZ | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WIZ mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2072 | 96-48-0 | YPEL2 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2073 | 96-48-0 | YPEL5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2074 | 96-48-0 | YWHAE | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of YWHAE mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2075 | 96-48-0 | ZBTB26 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB26 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2076 | 96-48-0 | ZBTB4 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB4 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2077 | 96-48-0 | ZC2HC1A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC2HC1A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2078 | 96-48-0 | ZC3H12A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC3H12A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2079 | 96-48-0 | ZDHHC7 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZDHHC7 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2080 | 96-48-0 | ZFAND2A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFAND2A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2081 | 96-48-0 | ZFYVE1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFYVE1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2082 | 96-48-0 | ZKSCAN1 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZKSCAN1 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2083 | 96-48-0 | ZMYM5 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZMYM5 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2084 | 96-48-0 | ZNF160 | Homo sapiens | 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ZNF160 mRNA | decreases^expression | 19167446 |
| 2085 | 96-48-0 | ZNF277 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF277 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2086 | 96-48-0 | ZNF292 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF292 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2087 | 96-48-0 | ZNF354A | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF354A mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2088 | 96-48-0 | ZNF367 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2089 | 96-48-0 | ZNF467 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF467 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2090 | 96-48-0 | ZNF641 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF641 mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2091 | 96-48-0 | ZNF703 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2092 | 96-48-0 | ZNF718 | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF718 mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2093 | 96-48-0 | ZWILCH | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWILCH mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2094 | 96-48-0 | ZWINT | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWINT mRNA | affects^cotreatment|increases^expression | 19167446 |
| 2095 | 96-48-0 | ZXDB | Homo sapiens | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZXDB mRNA | affects^cotreatment|decreases^expression | 19167446 |
| 2096 | 96-48-0 | FGF2 | 3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one affects the susceptibility to FGF2 protein | affects^response to substance | 19199859 | |
| 2097 | 96-48-0 | ATG5 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of ATG5 protein | decreases^expression | 28408137 |
| 2098 | 96-48-0 | ATG7 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of ATG7 protein | decreases^expression | 28408137 |
| 2099 | 96-48-0 | CTNNB1 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of CTNNB1 mRNA | decreases^expression | 26235807 |
| 2100 | 96-48-0 | EZH2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of EZH2 protein | decreases^expression | 26235807 |
| 2101 | 96-48-0 | JAK2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of JAK2 protein | decreases^expression | 26235807 |
| 2102 | 96-48-0 | JAK2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of JAK2 protein modified form | decreases^expression | 26235807 |
| 2103 | 96-48-0 | LGR5 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of LGR5 mRNA | decreases^expression | 26235807 |
| 2104 | 96-48-0 | LGR5 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of LGR5 protein | decreases^expression | 26235807 |
| 2105 | 96-48-0 | NANOG | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of NANOG protein | decreases^expression | 26235807 |
| 2106 | 96-48-0 | SMO | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of SMO mRNA | decreases^expression | 26235807 |
| 2107 | 96-48-0 | SOX2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of SOX2 mRNA | decreases^expression | 26235807 |
| 2108 | 96-48-0 | SUZ12 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of SUZ12 protein | decreases^expression | 26235807 |
| 2109 | 96-48-0 | TYK2 | Homo sapiens | 4-acetylantroquinonol B results in decreased expression of TYK2 protein | decreases^expression | 26235807 |
| 2110 | 96-48-0 | HPGDS | Mus musculus | [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA | affects^cotreatment|increases^expression | 21669866 |
| 2111 | 96-48-0 | HPGDS | Mus musculus | [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein | affects^cotreatment|increases^expression | 21669866 |
| 2112 | 96-48-0 | BIRC2 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC2 protein | decreases^expression | 21442130 |
| 2113 | 96-48-0 | BIRC3 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC3 protein | decreases^expression | 21442130 |
| 2114 | 96-48-0 | CASP3 | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in decreased expression of CASP3 protein | affects^cotreatment|decreases^expression|increases^cleavage | 21442130 |
| 2115 | 96-48-0 | CASP3 | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in increased activity of CASP3 protein | affects^cotreatment|increases^activity|increases^cleavage | 21442130 |
| 2116 | 96-48-0 | CASP3 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased cleavage of and results in increased activity of CASP3 protein | increases^activity|increases^cleavage | 21442130 |
| 2117 | 96-48-0 | CASP9 | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein | affects^cotreatment|increases^activity | 21442130 |
| 2118 | 96-48-0 | CASP9 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein | increases^activity | 21442130 |
| 2119 | 96-48-0 | CEBPA | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of CEBPA mRNA | decreases^expression | 15707987 |
| 2120 | 96-48-0 | DDIT3 | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased expression of DDIT3 mRNA | increases^expression | 17283163 |
| 2121 | 96-48-0 | FASN | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein | affects^binding|decreases^activity | 17847090 |
| 2122 | 96-48-0 | FASN | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein | affects^cotreatment|decreases^expression | 21442130 |
| 2123 | 96-48-0 | FASN | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein | decreases^activity | 21442130 |
| 2124 | 96-48-0 | FASN | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin | decreases^activity|increases^response to substance | 21442130 |
| 2125 | 96-48-0 | FASN | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA | decreases^expression | 15707987 |
| 2126 | 96-48-0 | FOS | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid affects the expression of FOS protein | affects^expression | 12724522 |
| 2127 | 96-48-0 | MET | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of MET protein | decreases^expression | 25971889 |
| 2128 | 96-48-0 | PPARG | Mus musculus | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA | decreases^expression | 15707987 |
| 2129 | 96-48-0 | PPP1R15A | Homo sapiens | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA | affects^cotreatment|increases^expression | 17283163 |
| 2130 | 96-48-0 | TOP2A | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of TOP2A protein | decreases^expression | 17089011 |
| 2131 | 96-48-0 | XIAP | Homo sapiens | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of XIAP protein | decreases^expression | 21442130 |
| 2132 | 96-48-0 | GSTA1 | Mus musculus | angelica lactone results in increased expression of GSTA1 protein | increases^expression | 11309284 |
| 2133 | 96-48-0 | GSTA2 | Mus musculus | angelica lactone results in increased expression of GSTA2 protein | increases^expression | 11309284 |
| 2134 | 96-48-0 | GSTA3 | Mus musculus | angelica lactone results in increased expression of GSTA3 protein | increases^expression | 11309284 |
| 2135 | 96-48-0 | GSTA4 | Mus musculus | angelica lactone results in increased expression of GSTA4 protein | increases^expression | 11309284 |
| 2136 | 96-48-0 | GSTM1 | Mus musculus | angelica lactone results in increased expression of GSTM1 protein | increases^expression | 11309284 |
| 2137 | 96-48-0 | GSTM5 | Mus musculus | angelica lactone results in increased expression of GSTM5 protein | increases^expression | 11309284 |
| 2138 | 96-48-0 | GSTP1 | Mus musculus | angelica lactone results in increased expression of GSTP1 protein | increases^expression | 11309284 |
| 2139 | 96-48-0 | GSTP2 | Mus musculus | angelica lactone results in increased expression of GSTP2 protein | increases^expression | 11309284 |
| 2140 | 96-48-0 | GSTT1 | Rattus norvegicus | angelica lactone results in increased expression of GSTT1 protein | increases^expression | 9855024 |
| 2141 | 96-48-0 | NFE2L2 | Mus musculus | angelica lactone affects the activity of NFE2L2 protein | affects^activity | 11309284 |
| 2142 | 96-48-0 | NQO1 | Mus musculus | angelica lactone results in increased expression of NQO1 protein | increases^expression | 11309284 |
| 2143 | 96-48-0 | NOS2 | Mus musculus | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases^reaction|increases^expression | 12721113 |
| 2144 | 96-48-0 | PTGS2 | Mus musculus | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases^reaction|increases^expression | 12721113 |
| 2145 | 96-48-0 | TNF | Homo sapiens | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF protein] | decreases^reaction|increases^expression | 12721113 |
| 2146 | 96-48-0 | TNF | Mus musculus | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF mRNA] | decreases^reaction|increases^expression | 12721113 |
| 2147 | 96-48-0 | PTGS2 | Rattus norvegicus | L 748706 results in decreased activity of PTGS2 protein | decreases^activity | 15878914 |
| 2148 | 96-48-0 | PTGS2 | Rattus norvegicus | Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] | decreases^activity|increases^reaction | 15878914 |
| 2149 | 96-48-0 | APP | Mus musculus | ligustilide results in decreased expression of APP protein | decreases^expression | 23973442 |
| 2150 | 96-48-0 | CAT | Mus musculus | ligustilide results in increased expression of and results in increased activity of CAT protein | increases^activity|increases^expression | 23973442 |
| 2151 | 96-48-0 | CYP3A4 | Homo sapiens | [ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | increases^activity|increases^expression | 21524698 |
| 2152 | 96-48-0 | HMOX1 | Mus musculus | ligustilide results in increased expression of HMOX1 mRNA | increases^expression | 23441843 |
| 2153 | 96-48-0 | HMOX1 | Mus musculus | ligustilide results in increased expression of HMOX1 protein | increases^expression | 23441843 |
| 2154 | 96-48-0 | KL | Homo sapiens | ligustilide results in increased expression of KL mRNA | increases^expression | 23973442 |
| 2155 | 96-48-0 | KL | Homo sapiens | ligustilide results in increased expression of KL protein | increases^expression | 23973442 |
| 2156 | 96-48-0 | NQO1 | Mus musculus | ligustilide results in increased expression of NQO1 mRNA | increases^expression | 23441843 |
| 2157 | 96-48-0 | NQO1 | Mus musculus | ligustilide results in increased expression of NQO1 protein | increases^expression | 23441843 |
| 2158 | 96-48-0 | NR1I2 | Homo sapiens | ligustilide results in increased activity of NR1I2 protein | increases^activity | 21524698 |
| 2159 | 96-48-0 | SOD2 | Mus musculus | ligustilide results in increased expression of and results in increased activity of SOD2 protein | increases^activity|increases^expression | 23973442 |
| 2160 | 96-48-0 | UGT1A1 | Mus musculus | ligustilide results in increased expression of UGT1A1 protein | increases^expression | 23441843 |
| 2161 | 96-48-0 | ALB | Bos taurus | methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate binds to and affects the folding of ALB protein | affects^binding|affects^folding | 22074127 |
| 2162 | 96-48-0 | CASP3 | Mus musculus | N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP3 protein | increases^activity | 25627690 |
| 2163 | 96-48-0 | CASP7 | Mus musculus | N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein | increases^activity | 25627690 |
| 2164 | 96-48-0 | P2RY2 | Homo sapiens | Ibuprofen inhibits the reaction [N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA] | decreases^expression|decreases^reaction | 10496880 |
| 2165 | 96-48-0 | P2RY2 | Homo sapiens | N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA | decreases^expression | 10496880 |
| 2166 | 96-48-0 | P2RY4 | Homo sapiens | N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY4 mRNA | decreases^expression | 10496880 |
| 2167 | 96-48-0 | PON2 | Homo sapiens | PON2 protein results in increased susceptibility to N-(3-oxododecanoyl)homoserine lactone | increases^response to substance | 25627690 |
| 2168 | 96-48-0 | P2RY2 | Homo sapiens | N-butyrylhomoserine lactone results in decreased expression of P2RY2 mRNA | decreases^expression | 10496880 |
| 2169 | 96-48-0 | P2RY4 | Homo sapiens | N-butyrylhomoserine lactone results in decreased expression of P2RY4 mRNA | decreases^expression | 10496880 |
| 2170 | 96-48-0 | BAX | Homo sapiens | protolichesterinic acid results in increased expression of BAX protein | increases^expression | 22063921 |
| 2171 | 96-48-0 | BCL2 | Homo sapiens | protolichesterinic acid results in decreased expression of BCL2 protein | decreases^expression | 22063921 |
| 2172 | 96-48-0 | CASP3 | Homo sapiens | protolichesterinic acid results in increased activity of CASP3 protein | increases^activity | 22063921 |
| 2173 | 96-48-0 | HSPA1A | Homo sapiens | protolichesterinic acid results in decreased expression of HSPA1A protein | decreases^expression | 22063921 |
| 2174 | 96-48-0 | NOS2 | Homo sapiens | protolichesterinic acid results in decreased expression of NOS2 protein | decreases^expression | 22063921 |
| 2175 | 96-48-0 | TNFSF10 | Homo sapiens | protolichesterinic acid results in increased expression of TNFSF10 protein | increases^expression | 22063921 |
| 2176 | 96-48-0 | CCL2 | spirodiclofen results in decreased expression of CCL2 | decreases^expression | 21788198 | |
| 2177 | 96-48-0 | CXCL10 | spirodiclofen results in increased expression of CXCL10 | increases^expression | 21788198 | |
| 2178 | 96-48-0 | SERPINE1 | spirodiclofen affects the expression of SERPINE1 | affects^expression | 21788198 |
| Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
|---|---|---|---|---|---|
| 1 | 96-48-0 | Butyro-1,4-lactone |
Compound Image
2D Structure
Download Sdf File Download PDB File Download MOL File
View Similar Structures (External DB)